JP2023522298A - 非悪性呼吸器疾患を処置及び予防するための組成物及び方法 - Google Patents
非悪性呼吸器疾患を処置及び予防するための組成物及び方法 Download PDFInfo
- Publication number
- JP2023522298A JP2023522298A JP2022557079A JP2022557079A JP2023522298A JP 2023522298 A JP2023522298 A JP 2023522298A JP 2022557079 A JP2022557079 A JP 2022557079A JP 2022557079 A JP2022557079 A JP 2022557079A JP 2023522298 A JP2023522298 A JP 2023522298A
- Authority
- JP
- Japan
- Prior art keywords
- thymus
- nmrd
- thymbra
- origanum
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 93
- 208000023504 respiratory system disease Diseases 0.000 title claims abstract description 18
- 230000003211 malignant effect Effects 0.000 title claims abstract description 15
- 239000000203 mixture Substances 0.000 title claims description 85
- 241000196324 Embryophyta Species 0.000 claims abstract description 130
- 239000004480 active ingredient Substances 0.000 claims abstract description 88
- 239000000284 extract Substances 0.000 claims abstract description 74
- 235000003434 Sesamum indicum Nutrition 0.000 claims abstract description 56
- 244000090896 Nigella sativa Species 0.000 claims abstract description 53
- 235000016698 Nigella sativa Nutrition 0.000 claims abstract description 52
- 240000002657 Thymus vulgaris Species 0.000 claims abstract description 47
- 235000007303 Thymus vulgaris Nutrition 0.000 claims abstract description 47
- 239000001585 thymus vulgaris Substances 0.000 claims abstract description 47
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 45
- 239000001711 nigella sativa Substances 0.000 claims abstract description 45
- 244000000231 Sesamum indicum Species 0.000 claims abstract description 39
- 244000290929 Coridothymus capitatus Species 0.000 claims abstract description 37
- 241000942070 Thymbra Species 0.000 claims abstract description 37
- 235000000294 Coridothymus capitatus Nutrition 0.000 claims abstract description 33
- 235000011228 Majorana syriaca Nutrition 0.000 claims abstract description 33
- 244000058518 Thymbra spicata Species 0.000 claims abstract description 33
- 235000005186 Thymbra spicata Nutrition 0.000 claims abstract description 32
- 244000264648 Rhus coriaria Species 0.000 claims abstract description 31
- 235000013178 Rhus coriaria Nutrition 0.000 claims abstract description 30
- 208000024891 symptom Diseases 0.000 claims abstract description 27
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 24
- 244000056927 Origanum maru Species 0.000 claims abstract 8
- 235000011203 Origanum Nutrition 0.000 claims description 34
- 239000008194 pharmaceutical composition Substances 0.000 claims description 34
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims description 33
- 240000004371 Panax ginseng Species 0.000 claims description 33
- 241001529744 Origanum Species 0.000 claims description 32
- 235000008434 ginseng Nutrition 0.000 claims description 31
- 239000004615 ingredient Substances 0.000 claims description 30
- 102000004169 proteins and genes Human genes 0.000 claims description 24
- 108090000623 proteins and genes Proteins 0.000 claims description 24
- 238000011282 treatment Methods 0.000 claims description 22
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims description 21
- 235000015872 dietary supplement Nutrition 0.000 claims description 21
- 235000002789 Panax ginseng Nutrition 0.000 claims description 20
- 229960005486 vaccine Drugs 0.000 claims description 19
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 18
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 16
- KEQHJBNSCLWCAE-UHFFFAOYSA-N thymoquinone Chemical compound CC(C)C1=CC(=O)C(C)=CC1=O KEQHJBNSCLWCAE-UHFFFAOYSA-N 0.000 claims description 16
- 230000002685 pulmonary effect Effects 0.000 claims description 14
- 241000700605 Viruses Species 0.000 claims description 13
- 244000269722 Thea sinensis Species 0.000 claims description 10
- 206010069351 acute lung injury Diseases 0.000 claims description 10
- 208000005069 pulmonary fibrosis Diseases 0.000 claims description 10
- 206010013975 Dyspnoeas Diseases 0.000 claims description 9
- 240000000783 Origanum majorana Species 0.000 claims description 9
- 239000005844 Thymol Substances 0.000 claims description 9
- 229960000790 thymol Drugs 0.000 claims description 9
- 208000000059 Dyspnea Diseases 0.000 claims description 8
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims description 8
- 208000006673 asthma Diseases 0.000 claims description 8
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 claims description 8
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 claims description 8
- 235000007746 carvacrol Nutrition 0.000 claims description 8
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims description 8
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 claims description 8
- 241000207923 Lamiaceae Species 0.000 claims description 7
- 206010035664 Pneumonia Diseases 0.000 claims description 7
- 208000015181 infectious disease Diseases 0.000 claims description 7
- 235000013616 tea Nutrition 0.000 claims description 7
- 108010004032 Bromelains Proteins 0.000 claims description 6
- 239000004365 Protease Substances 0.000 claims description 6
- 235000019835 bromelain Nutrition 0.000 claims description 6
- 230000000670 limiting effect Effects 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 208000002815 pulmonary hypertension Diseases 0.000 claims description 6
- 208000029523 Interstitial Lung disease Diseases 0.000 claims description 5
- 235000006297 Origanum majorana Nutrition 0.000 claims description 5
- 230000007502 viral entry Effects 0.000 claims description 5
- 208000033116 Asbestos intoxication Diseases 0.000 claims description 4
- 206010011224 Cough Diseases 0.000 claims description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 4
- 208000037656 Respiratory Sounds Diseases 0.000 claims description 4
- 206010039710 Scleroderma Diseases 0.000 claims description 4
- 201000010001 Silicosis Diseases 0.000 claims description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 4
- 206010047924 Wheezing Diseases 0.000 claims description 4
- 208000037883 airway inflammation Diseases 0.000 claims description 4
- 206010003441 asbestosis Diseases 0.000 claims description 4
- 201000009267 bronchiectasis Diseases 0.000 claims description 4
- 206010035653 pneumoconiosis Diseases 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 230000037390 scarring Effects 0.000 claims description 4
- 208000013220 shortness of breath Diseases 0.000 claims description 4
- 201000008827 tuberculosis Diseases 0.000 claims description 4
- 230000003612 virological effect Effects 0.000 claims description 4
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims description 3
- 235000017613 Aloysia Nutrition 0.000 claims description 3
- 241001505452 Aloysia Species 0.000 claims description 3
- 206010004485 Berylliosis Diseases 0.000 claims description 3
- 206010008469 Chest discomfort Diseases 0.000 claims description 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 3
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 claims description 3
- 240000002943 Elettaria cardamomum Species 0.000 claims description 3
- 201000005099 Langerhans cell histiocytosis Diseases 0.000 claims description 3
- 241000274183 Micromeria Species 0.000 claims description 3
- 206010029888 Obliterative bronchiolitis Diseases 0.000 claims description 3
- 241000208343 Panax Species 0.000 claims description 3
- 235000017276 Salvia Nutrition 0.000 claims description 3
- 235000006468 Thea sinensis Nutrition 0.000 claims description 3
- 240000001519 Verbena officinalis Species 0.000 claims description 3
- 235000018718 Verbena officinalis Nutrition 0.000 claims description 3
- 235000020279 black tea Nutrition 0.000 claims description 3
- 201000003848 bronchiolitis obliterans Diseases 0.000 claims description 3
- 208000023367 bronchiolitis obliterans with obstructive pulmonary disease Diseases 0.000 claims description 3
- 235000005300 cardamomo Nutrition 0.000 claims description 3
- 235000017803 cinnamon Nutrition 0.000 claims description 3
- 229940043350 citral Drugs 0.000 claims description 3
- 201000001981 dermatomyositis Diseases 0.000 claims description 3
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 claims description 3
- 229940013712 pineapple extract Drugs 0.000 claims description 3
- 208000005987 polymyositis Diseases 0.000 claims description 3
- 201000003651 pulmonary sarcoidosis Diseases 0.000 claims description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 3
- 235000002020 sage Nutrition 0.000 claims description 3
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims description 3
- 235000002791 Panax Nutrition 0.000 claims description 2
- 206010069363 Traumatic lung injury Diseases 0.000 claims description 2
- 240000007164 Salvia officinalis Species 0.000 claims 1
- 210000001541 thymus gland Anatomy 0.000 description 42
- 238000000605 extraction Methods 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 37
- 150000001875 compounds Chemical class 0.000 description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- -1 campferol Chemical compound 0.000 description 29
- 244000249805 Majorana syriaca Species 0.000 description 28
- 241000246354 Satureja Species 0.000 description 28
- 235000013399 edible fruits Nutrition 0.000 description 27
- 239000004863 Frankincense Substances 0.000 description 23
- 229930182490 saponin Natural products 0.000 description 23
- 235000017709 saponins Nutrition 0.000 description 23
- 240000000452 Sesamum alatum Species 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 235000009367 Sesamum alatum Nutrition 0.000 description 19
- 239000000341 volatile oil Substances 0.000 description 19
- 240000007551 Boswellia serrata Species 0.000 description 18
- 240000003152 Rhus chinensis Species 0.000 description 18
- 238000003556 assay Methods 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 235000014220 Rhus chinensis Nutrition 0.000 description 17
- 239000000126 substance Substances 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 16
- 150000007949 saponins Chemical class 0.000 description 16
- 239000002904 solvent Substances 0.000 description 16
- 201000010099 disease Diseases 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 239000011347 resin Substances 0.000 description 15
- 229920005989 resin Polymers 0.000 description 15
- 241000894007 species Species 0.000 description 15
- 208000019693 Lung disease Diseases 0.000 description 13
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 238000002347 injection Methods 0.000 description 11
- 239000007924 injection Substances 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 241001678559 COVID-19 virus Species 0.000 description 9
- 241000218170 Coriaria Species 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 235000018062 Boswellia Nutrition 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 238000010171 animal model Methods 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 8
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 229930003658 monoterpene Natural products 0.000 description 8
- 150000002989 phenols Chemical class 0.000 description 8
- 229920001282 polysaccharide Polymers 0.000 description 8
- 239000005017 polysaccharide Substances 0.000 description 8
- 230000013777 protein digestion Effects 0.000 description 8
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 150000003505 terpenes Chemical class 0.000 description 8
- 102100035765 Angiotensin-converting enzyme 2 Human genes 0.000 description 7
- 108090000975 Angiotensin-converting enzyme 2 Proteins 0.000 description 7
- 235000012035 Boswellia serrata Nutrition 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 235000007413 Nigella arvensis Nutrition 0.000 description 7
- 240000007673 Origanum vulgare Species 0.000 description 7
- 240000002114 Satureja hortensis Species 0.000 description 7
- 235000013361 beverage Nutrition 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 229930182494 ginsenoside Natural products 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 229920001461 hydrolysable tannin Polymers 0.000 description 7
- 238000004949 mass spectrometry Methods 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 102000005962 receptors Human genes 0.000 description 7
- 108020003175 receptors Proteins 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 240000009122 Satureja thymbra Species 0.000 description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 6
- 125000003118 aryl group Chemical group 0.000 description 6
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 6
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 229930195733 hydrocarbon Natural products 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 150000002773 monoterpene derivatives Chemical class 0.000 description 6
- 235000002577 monoterpenes Nutrition 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 239000002798 polar solvent Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 229910052711 selenium Inorganic materials 0.000 description 6
- 239000011669 selenium Substances 0.000 description 6
- 229930004725 sesquiterpene Natural products 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 6
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- 235000015987 Origanum dictamnus Nutrition 0.000 description 5
- 240000001359 Origanum dictamnus Species 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 241000208225 Rhus Species 0.000 description 5
- 241000283984 Rodentia Species 0.000 description 5
- 108091005609 SARS-CoV-2 Spike Subunit S1 Proteins 0.000 description 5
- 108091006367 SARS-CoV-2 Spike Subunit S2 Proteins 0.000 description 5
- 235000007315 Satureja hortensis Nutrition 0.000 description 5
- 240000006001 Thymus serpyllum Species 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 239000013566 allergen Substances 0.000 description 5
- 229960004784 allergens Drugs 0.000 description 5
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 235000010208 anthocyanin Nutrition 0.000 description 5
- 239000004410 anthocyanin Substances 0.000 description 5
- 229930002877 anthocyanin Natural products 0.000 description 5
- 150000004636 anthocyanins Chemical class 0.000 description 5
- 229910052796 boron Inorganic materials 0.000 description 5
- 229910052793 cadmium Inorganic materials 0.000 description 5
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 229930004069 diterpene Natural products 0.000 description 5
- 229960003180 glutathione Drugs 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 235000017807 phytochemicals Nutrition 0.000 description 5
- 229930000223 plant secondary metabolite Natural products 0.000 description 5
- 150000004804 polysaccharides Chemical class 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical group C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 description 4
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 4
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 4
- BPLQKQKXWHCZSS-UHFFFAOYSA-N Elemicin Chemical compound COC1=CC(CC=C)=CC(OC)=C1OC BPLQKQKXWHCZSS-UHFFFAOYSA-N 0.000 description 4
- GAEQWKVGMHUUKO-UHFFFAOYSA-N Girinimbine Chemical compound C1=CC(C)(C)OC2=C1C(NC1=CC=CC=C11)=C1C=C2C GAEQWKVGMHUUKO-UHFFFAOYSA-N 0.000 description 4
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- 241001530685 Origanum laevigatum Species 0.000 description 4
- 240000004373 Origanum onites Species 0.000 description 4
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 4
- 108010067390 Viral Proteins Proteins 0.000 description 4
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 4
- 230000010100 anticoagulation Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000010425 asbestos Substances 0.000 description 4
- 235000021028 berry Nutrition 0.000 description 4
- PYXFVCFISTUSOO-UHFFFAOYSA-N betulafolienetriol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4C(O)CC3C21C PYXFVCFISTUSOO-UHFFFAOYSA-N 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 238000011260 co-administration Methods 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 125000000567 diterpene group Chemical group 0.000 description 4
- 239000008298 dragée Substances 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 150000008195 galaktosides Chemical class 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 4
- 229930013032 isoflavonoid Natural products 0.000 description 4
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 4
- 235000012891 isoflavonoids Nutrition 0.000 description 4
- 235000008777 kaempferol Nutrition 0.000 description 4
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 4
- YLYBTZIQSIBWLI-UHFFFAOYSA-N octyl acetate Chemical compound CCCCCCCCOC(C)=O YLYBTZIQSIBWLI-UHFFFAOYSA-N 0.000 description 4
- 150000002894 organic compounds Chemical class 0.000 description 4
- 210000000414 pleural mesothelial cell Anatomy 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- SWQINCWATANGKN-UHFFFAOYSA-N protopanaxadiol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC21C SWQINCWATANGKN-UHFFFAOYSA-N 0.000 description 4
- 235000005875 quercetin Nutrition 0.000 description 4
- 229960001285 quercetin Drugs 0.000 description 4
- 229910052895 riebeckite Inorganic materials 0.000 description 4
- KQRXQIPRDKVZPW-UHFFFAOYSA-N sesaminol Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-UHFFFAOYSA-N 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 238000001256 steam distillation Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 235000007586 terpenes Nutrition 0.000 description 4
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 description 4
- KQAZVFVOEIRWHN-UHFFFAOYSA-N α-thujene Chemical compound CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 4
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 3
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 3
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241001529736 Monarda <angiosperm> Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 3
- 241001518101 Origanum bargyli Species 0.000 description 3
- 235000010677 Origanum vulgare Nutrition 0.000 description 3
- 241000629989 Origanum vulgare subsp. hirtum Species 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 3
- 229960004308 acetylcysteine Drugs 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 210000001552 airway epithelial cell Anatomy 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 208000018631 connective tissue disease Diseases 0.000 description 3
- OORMXZNMRWBSTK-LGFJJATJSA-N dammarane Chemical class C1CCC(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@H](C)CCCC(C)C)[C@H]4CC[C@@H]3[C@]21C OORMXZNMRWBSTK-LGFJJATJSA-N 0.000 description 3
- 238000000326 densiometry Methods 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 238000002481 ethanol extraction Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 229940107131 ginseng root Drugs 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 229930187479 gypenoside Natural products 0.000 description 3
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229930013686 lignan Natural products 0.000 description 3
- 235000009408 lignans Nutrition 0.000 description 3
- 150000005692 lignans Chemical class 0.000 description 3
- 235000001510 limonene Nutrition 0.000 description 3
- 229940087305 limonene Drugs 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- 238000004811 liquid chromatography Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000003808 methanol extraction Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- KQRXQIPRDKVZPW-ISZNXKAUSA-N sesaminol Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=3OCOC=3C=C2O)=C1 KQRXQIPRDKVZPW-ISZNXKAUSA-N 0.000 description 3
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 3
- 229940032091 stigmasterol Drugs 0.000 description 3
- 235000016831 stigmasterol Nutrition 0.000 description 3
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- WONIGEXYPVIKFS-UHFFFAOYSA-N (+)-cis-Verbenol Natural products CC1=CC(O)C2C(C)(C)C1C2 WONIGEXYPVIKFS-UHFFFAOYSA-N 0.000 description 2
- HGXBRUKMWQGOIE-AFHBHXEDSA-N (+)-pinoresinol Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O)=CC=3)CO2)=C1 HGXBRUKMWQGOIE-AFHBHXEDSA-N 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 2
- YJBVHJIKNLBFDX-MQURJEHKSA-N (3r,4r,4ar,6ar,6bs,8ar,11r,12s,12ar,14ar,14br)-3-acetyloxy-4,6a,6b,8a,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picene-4-carboxylic acid Chemical compound C1C[C@@H](OC(C)=O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C YJBVHJIKNLBFDX-MQURJEHKSA-N 0.000 description 2
- IHPKGUQCSIINRJ-CSKARUKUSA-N (E)-beta-ocimene Chemical compound CC(C)=CC\C=C(/C)C=C IHPKGUQCSIINRJ-CSKARUKUSA-N 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- QJYNZEYHSMRWBK-NIKIMHBISA-N 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose Chemical compound OC1=C(O)C(O)=CC(C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(O)C(O)=C(O)C=2)=C1 QJYNZEYHSMRWBK-NIKIMHBISA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- JZBCTZLGKSYRSF-UHFFFAOYSA-N 2-Ethyl-3,5-dimethylpyrazine Chemical compound CCC1=NC=C(C)N=C1C JZBCTZLGKSYRSF-UHFFFAOYSA-N 0.000 description 2
- ZFFTZDQKIXPDAF-UHFFFAOYSA-N 2-Furanmethanethiol Chemical compound SCC1=CC=CO1 ZFFTZDQKIXPDAF-UHFFFAOYSA-N 0.000 description 2
- DBZAKQWXICEWNW-UHFFFAOYSA-N 2-acetylpyrazine Chemical compound CC(=O)C1=CN=CC=N1 DBZAKQWXICEWNW-UHFFFAOYSA-N 0.000 description 2
- ZMRFRBHYXOQLDK-UHFFFAOYSA-N 2-phenylethanethiol Chemical compound SCCC1=CC=CC=C1 ZMRFRBHYXOQLDK-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one Chemical compound CC1OC(C)=C(O)C1=O INAXVXBDKKUCGI-UHFFFAOYSA-N 0.000 description 2
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 2
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 2
- 208000025721 COVID-19 Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 244000302413 Carum copticum Species 0.000 description 2
- 235000007034 Carum copticum Nutrition 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000014085 Chronic respiratory disease Diseases 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- AQASRZOCERRGBL-UHFFFAOYSA-N Dauricine Natural products CN1CCC2=CC(OC)=C(OC)C=C2C1CC1=CC=C(O)C(OC2=CC=C(C=C2)CC2N(C)CCC=3C=C(C(=CC=32)OC)OC)=C1 AQASRZOCERRGBL-UHFFFAOYSA-N 0.000 description 2
- 102000002045 Endothelin Human genes 0.000 description 2
- 108050009340 Endothelin Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- LHXDLQBQYFFVNW-UHFFFAOYSA-N Fenchone Chemical compound C1CC2(C)C(=O)C(C)(C)C1C2 LHXDLQBQYFFVNW-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 235000013628 Lantana involucrata Nutrition 0.000 description 2
- 208000004852 Lung Injury Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 2
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010028735 Nasal congestion Diseases 0.000 description 2
- 235000008750 Nigella damascena Nutrition 0.000 description 2
- 241001518100 Origanum amanum Species 0.000 description 2
- 241001537288 Origanum compactum Species 0.000 description 2
- 235000002328 Origanum compactum Nutrition 0.000 description 2
- 241000629995 Origanum microphyllum Species 0.000 description 2
- 235000000003 Origanum onites Nutrition 0.000 description 2
- 241000629996 Origanum scabrum Species 0.000 description 2
- 241000674867 Origanum sipyleum Species 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 description 2
- 208000020193 Pulmonary artery hypoplasia Diseases 0.000 description 2
- 206010037368 Pulmonary congestion Diseases 0.000 description 2
- 241000238711 Pyroglyphidae Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 241001206340 Rhus microphylla Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241001278097 Salix alba Species 0.000 description 2
- 241001072909 Salvia Species 0.000 description 2
- 241000612118 Samolus valerandi Species 0.000 description 2
- 241000162643 Satureja cuneifolia Species 0.000 description 2
- 241001246159 Satureja horvatii Species 0.000 description 2
- 241001561540 Satureja innota Species 0.000 description 2
- 241001598622 Satureja khuzistanica Species 0.000 description 2
- 235000017099 Satureja thymbra Nutrition 0.000 description 2
- 241001561594 Satureja thymbrifolia Species 0.000 description 2
- 241000018440 Saxifraga intricata Species 0.000 description 2
- 241000209056 Secale Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 2
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 2
- 101001024637 Severe acute respiratory syndrome coronavirus 2 Nucleoprotein Proteins 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 241001403967 Thymus marschallianus Species 0.000 description 2
- 235000017826 Thymus zygis Nutrition 0.000 description 2
- 244000157222 Thymus zygis Species 0.000 description 2
- 102100030951 Tissue factor pathway inhibitor Human genes 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- YTPJSSUCMUKHHN-UHFFFAOYSA-N Vomifoliol Natural products CC(O)C=CC1C(C)=CC(O)CC1(C)C YTPJSSUCMUKHHN-UHFFFAOYSA-N 0.000 description 2
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- IGODOXYLBBXFDW-UHFFFAOYSA-N alpha-Terpinyl acetate Chemical compound CC(=O)OC(C)(C)C1CCC(C)=CC1 IGODOXYLBBXFDW-UHFFFAOYSA-N 0.000 description 2
- BZXULBWGROURAF-UHFFFAOYSA-N alpha-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC3C21C BZXULBWGROURAF-UHFFFAOYSA-N 0.000 description 2
- XUEHVOLRMXNRKQ-KHMAMNHCSA-N alpha-cubebene Chemical compound CC(C)[C@@H]([C@H]12)CC[C@@H](C)[C@]32[C@@H]1C(C)=CC3 XUEHVOLRMXNRKQ-KHMAMNHCSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- GKHCBYYBLTXYEV-UJPOAAIJSA-N benzyl beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OCC1=CC=CC=C1 GKHCBYYBLTXYEV-UJPOAAIJSA-N 0.000 description 2
- NDVASEGYNIMXJL-UHFFFAOYSA-N beta-sabinene Natural products C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 2
- 210000000424 bronchial epithelial cell Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- AYMYWHCQALZEGT-ORCRQEGFSA-N butein Chemical compound OC1=CC(O)=CC=C1C(=O)\C=C\C1=CC=C(O)C(O)=C1 AYMYWHCQALZEGT-ORCRQEGFSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 229940117948 caryophyllene Drugs 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 239000002817 coal dust Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 229940052810 complex b Drugs 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 235000021532 culinary herbs Nutrition 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-Terpineol Chemical compound CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000012156 elution solvent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 230000003176 fibrotic effect Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- VGVYRHYDNGFIGF-UHFFFAOYSA-N fumarin Chemical compound OC=1OC2=CC=CC=C2C(=O)C=1C(CC(=O)C)C1=CC=CO1 VGVYRHYDNGFIGF-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229940046533 house dust mites Drugs 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229940043353 maltol Drugs 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000005399 mechanical ventilation Methods 0.000 description 2
- 230000034217 membrane fusion Effects 0.000 description 2
- FBSFWRHWHYMIOG-UHFFFAOYSA-N methyl 3,4,5-trihydroxybenzoate Chemical compound COC(=O)C1=CC(O)=C(O)C(O)=C1 FBSFWRHWHYMIOG-UHFFFAOYSA-N 0.000 description 2
- 238000000874 microwave-assisted extraction Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- BWORNNDZQGOKBY-UHFFFAOYSA-N ombuin Chemical compound C=1C(OC)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(OC)C(O)=C1 BWORNNDZQGOKBY-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 150000007875 phellandrene derivatives Chemical class 0.000 description 2
- ZJAOAACCNHFJAH-UHFFFAOYSA-N phosphonoformic acid Chemical compound OC(=O)P(O)(O)=O ZJAOAACCNHFJAH-UHFFFAOYSA-N 0.000 description 2
- 229940068065 phytosterols Drugs 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 235000007221 pinoresinol Nutrition 0.000 description 2
- OHOPKHNWLCMLSW-UHFFFAOYSA-N pinoresinol Natural products C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(CO)C(O)=CC=3)CO2)=C1 OHOPKHNWLCMLSW-UHFFFAOYSA-N 0.000 description 2
- 229920001197 polyacetylene Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 238000002953 preparative HPLC Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine acetate Natural products C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- HDDDNIUXSFCGMB-UHFFFAOYSA-N quercetin 3-galactoside Natural products OCC1OC(OC2=C(Oc3ccc(O)c(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C(O)C1O HDDDNIUXSFCGMB-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 239000002341 toxic gas Substances 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 150000008130 triterpenoid saponins Chemical class 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- KPQMCAKZRXOZLB-AATRIKPKSA-N vomifoliol Chemical compound CC(O)\C=C\C1(O)C(C)=CC(=O)CC1(C)C KPQMCAKZRXOZLB-AATRIKPKSA-N 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- BURBOJZOZGMMQF-UHFFFAOYSA-N xanthoxylol Natural products C1=C(O)C(OC)=CC=C1C1C(COC2C=3C=C4OCOC4=CC=3)C2CO1 BURBOJZOZGMMQF-UHFFFAOYSA-N 0.000 description 2
- LHXDLQBQYFFVNW-XCBNKYQSSA-N (+)-Fenchone Natural products C1C[C@]2(C)C(=O)C(C)(C)[C@H]1C2 LHXDLQBQYFFVNW-XCBNKYQSSA-N 0.000 description 1
- WRHGORWNJGOVQY-KKUMJFAQSA-N (+)-gamma-cadinene Chemical compound C1CC(C)=C[C@H]2[C@H](C(C)C)CCC(=C)[C@@H]21 WRHGORWNJGOVQY-KKUMJFAQSA-N 0.000 description 1
- MHXCIKYXNYCMHY-AUSJPIAWSA-N (+)-lariciresinol Chemical compound C1=C(O)C(OC)=CC(C[C@@H]2[C@@H]([C@H](OC2)C=2C=C(OC)C(O)=CC=2)CO)=C1 MHXCIKYXNYCMHY-AUSJPIAWSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- GAIBLDCXCZKKJE-QRYCCKSOSA-N (-)-Germacrene D Natural products C(C)(C)[C@H]1/C=C/C(=C)CC/C=C(/C)\CC1 GAIBLDCXCZKKJE-QRYCCKSOSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- ZIOZYRSDNLNNNJ-IBGZPJMESA-N (12s)-12-hydroperoxyicosa-5,8,10,14-tetraenoic acid Chemical compound CCCCCC=CC[C@H](OO)C=CC=CCC=CCCCC(O)=O ZIOZYRSDNLNNNJ-IBGZPJMESA-N 0.000 description 1
- DMHADBQKVWXPPM-PDDCSNRZSA-N (1e,3z,6e,10z,14s)-3,7,11-trimethyl-14-propan-2-ylcyclotetradeca-1,3,6,10-tetraene Chemical compound CC(C)[C@@H]\1CC\C(C)=C/CC\C(C)=C\C\C=C(\C)/C=C/1 DMHADBQKVWXPPM-PDDCSNRZSA-N 0.000 description 1
- WONIGEXYPVIKFS-HRDYMLBCSA-N (1r,2r,5r)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ol Chemical compound CC1=C[C@@H](O)[C@H]2C(C)(C)[C@@H]1C2 WONIGEXYPVIKFS-HRDYMLBCSA-N 0.000 description 1
- WONIGEXYPVIKFS-VGMNWLOBSA-N (1r,2s,5r)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-ol Chemical compound CC1=C[C@H](O)[C@H]2C(C)(C)[C@@H]1C2 WONIGEXYPVIKFS-VGMNWLOBSA-N 0.000 description 1
- JZQKTMZYLHNFPL-BLHCBFLLSA-N (2E,4E)-deca-2,4-dienal Chemical compound CCCCC\C=C\C=C\C=O JZQKTMZYLHNFPL-BLHCBFLLSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical class O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 1
- QGGOCWIJGWDKHC-FSIIMWSLSA-N (2s,3s,4r,5r)-2,4,5-trihydroxy-3-methoxy-6-oxohexanoic acid Chemical compound OC(=O)[C@@H](O)[C@@H](OC)[C@H](O)[C@@H](O)C=O QGGOCWIJGWDKHC-FSIIMWSLSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- XIIAYQZJNBULGD-UHFFFAOYSA-N (5alpha)-cholestane Natural products C1CC2CCCCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XIIAYQZJNBULGD-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 description 1
- WWRCMNKATXZARA-UHFFFAOYSA-N 1-Isopropyl-2-methylbenzene Chemical compound CC(C)C1=CC=CC=C1C WWRCMNKATXZARA-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- ARNKHYQYAZLEEP-UHFFFAOYSA-N 1-naphthalen-1-yloxynaphthalene Chemical compound C1=CC=C2C(OC=3C4=CC=CC=C4C=CC=3)=CC=CC2=C1 ARNKHYQYAZLEEP-UHFFFAOYSA-N 0.000 description 1
- 101710102211 11S globulin Proteins 0.000 description 1
- VCNKUCWWHVTTBY-UHFFFAOYSA-N 18alpha-Oleanane Natural products C1CCC(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4CCC3C21C VCNKUCWWHVTTBY-UHFFFAOYSA-N 0.000 description 1
- HSDXVAOHEOSTFZ-UHFFFAOYSA-N 2-Pentylpyridine Chemical compound CCCCCC1=CC=CC=N1 HSDXVAOHEOSTFZ-UHFFFAOYSA-N 0.000 description 1
- DQBQWWSFRPLIAX-UHFFFAOYSA-N 2-acetyl-1-pyrroline Chemical compound CC(=O)C1=NCCC1 DQBQWWSFRPLIAX-UHFFFAOYSA-N 0.000 description 1
- 239000001363 2-ethyl-3,5-dimethylpyrazine Substances 0.000 description 1
- HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
- YOMSJEATGXXYPX-UHFFFAOYSA-N 2-methoxy-4-vinylphenol Chemical compound COC1=CC(C=C)=CC=C1O YOMSJEATGXXYPX-UHFFFAOYSA-N 0.000 description 1
- LOTYADDQWWVBDJ-UHFFFAOYSA-N 2-methyl-2-nitropropane-1,3-diol Chemical compound OCC(C)(CO)[N+]([O-])=O LOTYADDQWWVBDJ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- 101710168820 2S seed storage albumin protein Proteins 0.000 description 1
- ZVWXZFYWLABNOW-XBMWAWDJSA-N 3,7,11-cembratrien-1-ol Chemical compound CC(C)C1(O)CC\C(C)=C/CC\C(C)=C/CC\C(C)=C/C1 ZVWXZFYWLABNOW-XBMWAWDJSA-N 0.000 description 1
- XMTQQYYKAHVGBJ-UHFFFAOYSA-N 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA Chemical compound CN(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XMTQQYYKAHVGBJ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 1
- WAAWMJYYKITCGF-WTPIMUJOSA-N 5alpha-ergostane Chemical compound C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@H](C)C(C)C)[C@@]2(C)CC1 WAAWMJYYKITCGF-WTPIMUJOSA-N 0.000 description 1
- GKBHKNPLNHLYHT-UHFFFAOYSA-N 5beta-Stigmastan Natural products C1CC2CCCCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 GKBHKNPLNHLYHT-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000036065 Airway Remodeling Diseases 0.000 description 1
- 102000002572 Alpha-Globulins Human genes 0.000 description 1
- 108010068307 Alpha-Globulins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 241001563177 Argantoniella salzmannii Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001473009 Barnadesioideae Species 0.000 description 1
- 102000006734 Beta-Globulins Human genes 0.000 description 1
- 108010087504 Beta-Globulins Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 description 1
- 206010006448 Bronchiolitis Diseases 0.000 description 1
- 241000208229 Burseraceae Species 0.000 description 1
- 102000000905 Cadherin Human genes 0.000 description 1
- 108050007957 Cadherin Proteins 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 241000220270 Cephalotus Species 0.000 description 1
- VWFCHDSQECPREK-LURJTMIESA-N Cidofovir Chemical compound NC=1C=CN(C[C@@H](CO)OCP(O)(O)=O)C(=O)N=1 VWFCHDSQECPREK-LURJTMIESA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241001642966 Corymbioideae Species 0.000 description 1
- 101710190853 Cruciferin Proteins 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 102000004237 Decorin Human genes 0.000 description 1
- 108090000738 Decorin Proteins 0.000 description 1
- RRYLZZSYDRTJEL-UHFFFAOYSA-N Delphidin Natural products CCN1CC2(COC)CCC(O)C34C5CC6C(O)C5C(CC6OC)(OC(=O)C)C(C(O)C23)C14 RRYLZZSYDRTJEL-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 101100186820 Drosophila melanogaster sicily gene Proteins 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 241001110062 Euphrasia officinalis Species 0.000 description 1
- 108010054265 Factor VIIa Proteins 0.000 description 1
- 241001527180 Famatinanthoideae Species 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000506900 Garidella nigellastrum Species 0.000 description 1
- GAIBLDCXCZKKJE-YZJXYJLZSA-N Germacren D Chemical compound CC(C)C/1CC\C(C)=C\CCC(=C)\C=C\1 GAIBLDCXCZKKJE-YZJXYJLZSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 241000282375 Herpestidae Species 0.000 description 1
- 241000228404 Histoplasma capsulatum Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- RKWHWFONKJEUEF-WVXKDWSHSA-O Idaein Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 RKWHWFONKJEUEF-WVXKDWSHSA-O 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 235000005769 Japanese ginseng Nutrition 0.000 description 1
- OFFWOVJBSQMVPI-RMLGOCCBSA-N Kaletra Chemical compound N1([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)COC=2C(=CC=CC=2C)C)CC=2C=CC=CC=2)CCCNC1=O.N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 OFFWOVJBSQMVPI-RMLGOCCBSA-N 0.000 description 1
- 241000212281 Lagoecia cuminoides Species 0.000 description 1
- 241000134253 Lanka Species 0.000 description 1
- YVRYZXAHRGGELT-UHFFFAOYSA-N Lariciresinol Natural products C1=C2OCOC2=CC(C2C(C)C3(OC)C=C(CC=C)C(=O)CC3(O2)OC)=C1 YVRYZXAHRGGELT-UHFFFAOYSA-N 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 208000032376 Lung infection Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010051604 Lung transplant rejection Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000006166 Metallocarboxypeptidases Human genes 0.000 description 1
- 108030000089 Metallocarboxypeptidases Proteins 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010669 Monarda fistulosa Nutrition 0.000 description 1
- 240000007508 Monarda fistulosa Species 0.000 description 1
- 241000717677 Mosla chinensis Species 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 240000008338 Nigella arvensis Species 0.000 description 1
- 241000695162 Nigella carpatha Species 0.000 description 1
- 240000005912 Nigella damascena Species 0.000 description 1
- 241000695158 Nigella degenii Species 0.000 description 1
- 241000506907 Nigella doerfleri Species 0.000 description 1
- 241000506906 Nigella elata Species 0.000 description 1
- 241000506912 Nigella gallica Species 0.000 description 1
- 235000002080 Nigella orientalis Nutrition 0.000 description 1
- 244000120943 Nigella orientalis Species 0.000 description 1
- 241000506910 Nigella oxypetala Species 0.000 description 1
- 241000506915 Nigella papillosa Species 0.000 description 1
- 229930189092 Notoginsenoside Natural products 0.000 description 1
- HVBACKJYWZTKCA-XSLBTUIJSA-N O1[C@]2(C)CC[C@@]1(C(C)C)C/C=C(C)/CC/C=C(C)/CC[C@@H]2OC(C)=O Chemical compound O1[C@]2(C)CC[C@@]1(C(C)C)C/C=C(C)/CC/C=C(C)/CC[C@@H]2OC(C)=O HVBACKJYWZTKCA-XSLBTUIJSA-N 0.000 description 1
- QGGOCWIJGWDKHC-UHFFFAOYSA-N O4-Methyl-D-glucuronsaeure Natural products OC(=O)C(O)C(OC)C(O)C(O)C=O QGGOCWIJGWDKHC-UHFFFAOYSA-N 0.000 description 1
- 206010073310 Occupational exposures Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241001518097 Origanum acutidens Species 0.000 description 1
- 241001518098 Origanum bilgeri Species 0.000 description 1
- 241001518099 Origanum boissieri Species 0.000 description 1
- 241001518087 Origanum calcaratum Species 0.000 description 1
- 241001518088 Origanum cordifolium Species 0.000 description 1
- 241001561561 Origanum dayi Species 0.000 description 1
- 235000017666 Origanum dayi Nutrition 0.000 description 1
- 241001561559 Origanum elongatum Species 0.000 description 1
- 235000017665 Origanum elongatum Nutrition 0.000 description 1
- 241001518084 Origanum haussknechtii Species 0.000 description 1
- 241001518070 Origanum husnucan-baseri Species 0.000 description 1
- 241001518068 Origanum hypericifolium Species 0.000 description 1
- 235000003388 Origanum laevigatum Nutrition 0.000 description 1
- 241001518069 Origanum leptocladum Species 0.000 description 1
- 235000017600 Origanum microphyllum Nutrition 0.000 description 1
- 241001518075 Origanum minutiflorum Species 0.000 description 1
- 235000006669 Origanum minutiflorum Nutrition 0.000 description 1
- 241001518071 Origanum munzurense Species 0.000 description 1
- 241001518072 Origanum ramonense Species 0.000 description 1
- 241001561568 Origanum rotundifolium Species 0.000 description 1
- 235000017721 Origanum rotundifolium Nutrition 0.000 description 1
- 241001518055 Origanum saccatum Species 0.000 description 1
- 235000017603 Origanum scabrum Nutrition 0.000 description 1
- 241001518058 Origanum solymicum Species 0.000 description 1
- 241000629988 Origanum vulgare subsp. virens Species 0.000 description 1
- 241001515808 Origanum x adanense Species 0.000 description 1
- 241000291043 Origanum x majoricum Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000168720 Panax japonicus Species 0.000 description 1
- 235000003174 Panax japonicus Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 241000142787 Pneumocystis jirovecii Species 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000243142 Porifera Species 0.000 description 1
- 229940096437 Protein S Drugs 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 206010037437 Pulmonary thrombosis Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000002200 Respiratory Hypersensitivity Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000228636 Rhinolophus Species 0.000 description 1
- 244000296615 Rhus aromatica Species 0.000 description 1
- 235000014248 Rhus aromatica Nutrition 0.000 description 1
- 235000013234 Rhus glabra Nutrition 0.000 description 1
- 240000008599 Rhus glabra Species 0.000 description 1
- 235000013238 Rhus integrifolia Nutrition 0.000 description 1
- 244000262969 Rhus integrifolia Species 0.000 description 1
- 241001206336 Rhus kearneyi Species 0.000 description 1
- 241000871355 Rhus lanceolata Species 0.000 description 1
- 241000871356 Rhus sandwicensis Species 0.000 description 1
- 244000262668 Rhus taitensis Species 0.000 description 1
- 244000289376 Rhus trilobata Species 0.000 description 1
- 235000016935 Rhus trilobata var. trilobata Nutrition 0.000 description 1
- 235000013831 Rhus typhina Nutrition 0.000 description 1
- 240000004901 Rhus typhina Species 0.000 description 1
- 241000871330 Rhus virens Species 0.000 description 1
- 241000265322 Rhynchostele ehrenbergii Species 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 108091006197 SARS-CoV-2 Nucleocapsid Protein Proteins 0.000 description 1
- 241000230861 Satureja bachtiarica Species 0.000 description 1
- 241001561546 Satureja intermedia Species 0.000 description 1
- 241001561545 Satureja linearifolia Species 0.000 description 1
- 241000246337 Satureja montana Species 0.000 description 1
- 241000942064 Satureja mutica Species 0.000 description 1
- 241001561593 Satureja pallaryi Species 0.000 description 1
- 241001561597 Satureja parnassica Species 0.000 description 1
- 241001561596 Satureja pilosa Species 0.000 description 1
- 241000973109 Satureja spicigera Species 0.000 description 1
- 241001561595 Satureja spinosa Species 0.000 description 1
- 241000162467 Satureja subspicata Species 0.000 description 1
- 241000162468 Satureja visianii Species 0.000 description 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 1
- 241000063406 Sesamum lepidotum Species 0.000 description 1
- 241000780356 Sesamum marlothii Species 0.000 description 1
- 241000063411 Sesamum rigidum Species 0.000 description 1
- 241000343709 Sesamum schinzianum Species 0.000 description 1
- 241000294481 Sesamum triphyllum Species 0.000 description 1
- 101000629318 Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 101710198474 Spike protein Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241001561591 Thymbra calostachya Species 0.000 description 1
- 241000128788 Thymbra capitata Species 0.000 description 1
- 241001561590 Thymbra sintenisii Species 0.000 description 1
- 241001518156 Thymus altaicus Species 0.000 description 1
- 241001404003 Thymus amurensis Species 0.000 description 1
- 241001246160 Thymus bracteosus Species 0.000 description 1
- 235000017701 Thymus broussonetii Nutrition 0.000 description 1
- 244000046316 Thymus broussonetii Species 0.000 description 1
- 235000017717 Thymus caespititius Nutrition 0.000 description 1
- 240000006321 Thymus caespititius Species 0.000 description 1
- 241000475665 Thymus cilicicus Species 0.000 description 1
- 235000013130 Thymus herba barona Nutrition 0.000 description 1
- 240000005433 Thymus herba barona Species 0.000 description 1
- 241001515819 Thymus leucotrichus Species 0.000 description 1
- 241001192188 Thymus longicaulis Species 0.000 description 1
- 241001404001 Thymus mandschuricus Species 0.000 description 1
- 235000007236 Thymus mastichina Nutrition 0.000 description 1
- 240000006219 Thymus mastichina Species 0.000 description 1
- 241001403962 Thymus mongolicus Species 0.000 description 1
- 241000793689 Thymus odoratissimus Species 0.000 description 1
- 235000001522 Thymus pannonicus Nutrition 0.000 description 1
- 241000754257 Thymus praecox Species 0.000 description 1
- 241001403963 Thymus proximus Species 0.000 description 1
- 235000017715 Thymus pulegioides Nutrition 0.000 description 1
- 244000238515 Thymus pulegioides Species 0.000 description 1
- 241000329467 Thymus quinquecostatus Species 0.000 description 1
- 235000004054 Thymus serpyllum Nutrition 0.000 description 1
- 241001585743 Thymus sibthorpii Species 0.000 description 1
- 241001192185 Thymus striatus Species 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- 241000863480 Vinca Species 0.000 description 1
- 102000018265 Virus Receptors Human genes 0.000 description 1
- 108010066342 Virus Receptors Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000035472 Zoonoses Diseases 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229960001997 adefovir Drugs 0.000 description 1
- WOZSCQDILHKSGG-UHFFFAOYSA-N adefovir depivoxil Chemical compound N1=CN=C2N(CCOCP(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C)C=NC2=C1N WOZSCQDILHKSGG-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940040563 agaric acid Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 210000005091 airway smooth muscle Anatomy 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical group OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- IGODOXYLBBXFDW-NSHDSACASA-N alpha-Terpinyl acetate Natural products CC(=O)OC(C)(C)[C@@H]1CCC(C)=CC1 IGODOXYLBBXFDW-NSHDSACASA-N 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- SJMCNAVDHDBMLL-UHFFFAOYSA-N alpha-amyrin Natural products CC1CCC2(C)CCC3(C)C(=CCC4C5(C)CCC(O)CC5CCC34C)C2C1C SJMCNAVDHDBMLL-UHFFFAOYSA-N 0.000 description 1
- PSVBPLKYDMHILE-UHFFFAOYSA-N alpha-humulene Natural products CC1=C/CC(C)(C)C=CCC=CCC1 PSVBPLKYDMHILE-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- RHZUVFJBSILHOK-UHFFFAOYSA-N anthracen-1-ylmethanolate Chemical compound C1=CC=C2C=C3C(C[O-])=CC=CC3=CC2=C1 RHZUVFJBSILHOK-UHFFFAOYSA-N 0.000 description 1
- 239000003830 anthracite Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002259 anti human immunodeficiency virus agent Substances 0.000 description 1
- 230000002300 anti-fibrosis Effects 0.000 description 1
- 230000003510 anti-fibrotic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003097 anti-respiratory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 229940127090 anticoagulant agent Drugs 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940124748 beta 2 agonist Drugs 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 229940115397 bornyl acetate Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 229960001169 brivudine Drugs 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229960004424 carbon dioxide Drugs 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 238000000423 cell based assay Methods 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- DMHADBQKVWXPPM-SBHJBAJOSA-N cembrene Natural products CC(C)C1CCC(=C/CCC(=CCC=C(C)/C=C/1)C)C DMHADBQKVWXPPM-SBHJBAJOSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- XIIAYQZJNBULGD-LDHZKLTISA-N cholestane Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 XIIAYQZJNBULGD-LDHZKLTISA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229960000724 cidofovir Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- WONIGEXYPVIKFS-YIZRAAEISA-N cis-Verbenol Natural products CC1=C[C@H](O)[C@@H]2C(C)(C)[C@H]1C2 WONIGEXYPVIKFS-YIZRAAEISA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000010549 co-Evaporation Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- YOCDGWMCBBMMGJ-UHFFFAOYSA-N delta-cadinene Natural products C1C=C(C)CC2C(C(C)C)CCC(=C)C21 YOCDGWMCBBMMGJ-UHFFFAOYSA-N 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- 235000007882 dietary composition Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 239000005293 duran Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940079360 enema for constipation Drugs 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000007705 epithelial mesenchymal transition Effects 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229940012414 factor viia Drugs 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930006735 fenchone Natural products 0.000 description 1
- 235000008541 fennel flower Nutrition 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930183708 floralginsenoside Natural products 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229960001447 fomivirsen Drugs 0.000 description 1
- XCWFZHPEARLXJI-UHFFFAOYSA-N fomivirsen Chemical compound C1C(N2C3=C(C(NC(N)=N3)=O)N=C2)OC(CO)C1OP(O)(=S)OCC1OC(N(C)C(=O)\N=C(\N)C=C)CC1OP(O)(=S)OCC1OC(N2C3=C(C(NC(N)=N3)=O)N=C2)CC1OP(O)(=S)OCC1OC(N2C(NC(=O)C(C)=C2)=O)CC1OP(O)(=S)OCC1OC(N2C(NC(=O)C(C)=C2)=O)CC1OP(O)(=S)OCC1OC(N2C(NC(=O)C(C)=C2)=O)CC1OP(O)(=S)OCC1OC(N2C3=C(C(NC(N)=N3)=O)N=C2)CC1OP(O)(=S)OCC1OC(N2C(N=C(N)C=C2)=O)CC1OP(O)(=S)OCC(C(C1)OP(S)(=O)OCC2C(CC(O2)N2C(N=C(N)C=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=S)OCC2C(CC(O2)N2C(N=C(N)C=C2)=O)OP(O)(=S)OCC2C(CC(O2)N2C3=C(C(NC(N)=N3)=O)N=C2)O)OC1N1C=C(C)C(=O)NC1=O XCWFZHPEARLXJI-UHFFFAOYSA-N 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 229960002848 formoterol Drugs 0.000 description 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
- 229960005102 foscarnet Drugs 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000002316 fumigant Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000007499 fusion processing Methods 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229920002824 gallotannin Polymers 0.000 description 1
- JBHJOURGKXURIW-UHFFFAOYSA-N gamma-cadinene Natural products CC(C)C1CCC(=C2CCC(=C)CC12)C JBHJOURGKXURIW-UHFFFAOYSA-N 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002963 ganciclovir Drugs 0.000 description 1
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- OJIGFVZZEVQUNV-UHFFFAOYSA-N germacrene D Natural products CC(C)C1CCC=C(/C)CCC(=C)C=C1 OJIGFVZZEVQUNV-UHFFFAOYSA-N 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 244000000013 helminth Species 0.000 description 1
- ODZBBRURCPAEIQ-PIXDULNESA-N helpin Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(\C=C\Br)=C1 ODZBBRURCPAEIQ-PIXDULNESA-N 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- HLFVFEBKCLAGBY-UHFFFAOYSA-N hinokiflavone Natural products Oc1ccc(cc1)C2=COc3cc(O)c(Oc4ccc(cc4)C5=CC(=O)c6c(O)cc(O)cc6O5)c(O)c3C2=O HLFVFEBKCLAGBY-UHFFFAOYSA-N 0.000 description 1
- WTDHMFBJQJSTMH-UHFFFAOYSA-N hinokiflavone Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(OC=3C=CC(=CC=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)=C(O)C=C2O1 WTDHMFBJQJSTMH-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002727 hyperosmolar Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000004047 hyperresponsiveness Effects 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- SIOMFBXUIJKTMF-UHFFFAOYSA-N hypoglauterpenic acid Natural products C1CC(O)C(C)(C)C2=CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C SIOMFBXUIJKTMF-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- HVBACKJYWZTKCA-FSSWDIPSSA-N incensole acetate Natural products CC(C)[C@]12CC[C@](C)(O1)[C@@H](CCC(C)=CCCC(C)=CC2)OC(C)=O HVBACKJYWZTKCA-FSSWDIPSSA-N 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000000185 intracerebroventricular administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 238000012977 invasive surgical procedure Methods 0.000 description 1
- GAIBLDCXCZKKJE-UHFFFAOYSA-N isogermacrene D Natural products CC(C)C1CCC(C)=CCCC(=C)C=C1 GAIBLDCXCZKKJE-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000006826 lariciresinol Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 235000015122 lemonade Nutrition 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229940127212 long-acting beta 2 agonist Drugs 0.000 description 1
- 229940120922 lopinavir and ritonavir Drugs 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- WAFDWKYNSTVECG-UHFFFAOYSA-L magnesium;3-[(4-nitrophenyl)methoxy]-3-oxopropanoate Chemical compound [Mg+2].[O-]C(=O)CC(=O)OCC1=CC=C([N+]([O-])=O)C=C1.[O-]C(=O)CC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 WAFDWKYNSTVECG-UHFFFAOYSA-L 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- IBKQQKPQRYUGBJ-UHFFFAOYSA-N methyl gallate Natural products CC(=O)C1=CC(O)=C(O)C(O)=C1 IBKQQKPQRYUGBJ-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 208000018781 mild bronchitis Diseases 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 244000309711 non-enveloped viruses Species 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 231100000675 occupational exposure Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- BPAWXSVOAOLSRP-UHFFFAOYSA-N oleanane Natural products CCCCCCCCCCCCCCCC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5CC(C)(C)CCC5(C)C(O)CC34C)C1(C)C BPAWXSVOAOLSRP-UHFFFAOYSA-N 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003791 organic solvent mixture Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000002638 palliative care Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229960001179 penciclovir Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 description 1
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002206 pro-fibrotic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 150000003815 prostacyclins Chemical class 0.000 description 1
- 108010071967 protein K Proteins 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000012514 protein characterization Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical group C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- RWWYLEGWBNMMLJ-MEUHYHILSA-N remdesivir Drugs C([C@@H]1[C@H]([C@@H](O)[C@@](C#N)(O1)C=1N2N=CN=C(N)C2=CC=1)O)OP(=O)(N[C@@H](C)C(=O)OCC(CC)CC)OC1=CC=CC=C1 RWWYLEGWBNMMLJ-MEUHYHILSA-N 0.000 description 1
- RWWYLEGWBNMMLJ-YSOARWBDSA-N remdesivir Chemical group NC1=NC=NN2C1=CC=C2[C@]1([C@@H]([C@@H]([C@H](O1)CO[P@](=O)(OC1=CC=CC=C1)N[C@H](C(=O)OCC(CC)CC)C)O)O)C#N RWWYLEGWBNMMLJ-YSOARWBDSA-N 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000036454 renin-angiotensin system Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 229960000888 rimantadine Drugs 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 229960004017 salmeterol Drugs 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 239000001773 satureia montana l. Substances 0.000 description 1
- ZVWXZFYWLABNOW-UHFFFAOYSA-N serratol Natural products CC(C)C1(O)CCC(C)=CCCC(C)=CCCC(C)=CC1 ZVWXZFYWLABNOW-UHFFFAOYSA-N 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000012439 solid excipient Substances 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- GKBHKNPLNHLYHT-LWQAOISPSA-N stigmastane Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 GKBHKNPLNHLYHT-LWQAOISPSA-N 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229960004556 tenofovir Drugs 0.000 description 1
- VCMJCVGFSROFHV-WZGZYPNHSA-N tenofovir disoproxil fumarate Chemical compound OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N VCMJCVGFSROFHV-WZGZYPNHSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 229960001028 zanamivir Drugs 0.000 description 1
- ARAIBEBZBOPLMB-UFGQHTETSA-N zanamivir Chemical compound CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO ARAIBEBZBOPLMB-UFGQHTETSA-N 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/314—Foods, ingredients or supplements having a functional effect on health having an effect on lung or respiratory system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Pediatric Medicine (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
Abstract
Description
本発明のいくつかの実施形態は、単なる例として、添付の図面を参照して本明細書に記載される。ここで特に図面を詳細に参照すると、示されている特徴は一例であり、本発明の実施形態の例示的な議論の目的のためであることが強調される。この関連で、図面を用いた説明は、本発明の実施形態がどのように実施され得るかを当業者に明らかにする。図面において:
浸漬:接触段階は室温で維持される。
煮だし又は還流:接触段階は、溶媒の沸点に維持される。
温浸:接触段階は、前の2つの場合の間の温度に維持される。
浸出(infusion):沸騰溶媒を固体上に注ぎ、次いで、設定時間冷却したままにする。
濾過又は浸出(percolaton):溶媒がバイオマスを通過する。
2009年4月にレバノンで無作為に、S.シンブラ(S.thymbra)から空気乾燥した空気中部分を収集した。3時間、クレベンジャー型装置を用いて植物材料を水蒸気蒸留に供して、精油を収率0.84%(w/w)で生成した。無水硫酸マグネシウムを用いて油を乾燥し、4℃で保存する。S.シンブラ(S.thymbra)油をGC/MSで分析した。
ルス・コリアリア(Rhus coriaria)果実から化合物を単離、決定及び同定するために、スマック植物の果実又は葉から異なる抽出物を採取する。いくつかは水性抽出物から単離され、他はアルコール抽出物から単離され、いくつかは脂質抽出物から単離される。加水分解性タンニンは、スマック果実中で最も高い割合を構成し、次いでフラボノイドである。このことは、果実の抗酸化能を強調する。果実の質量のほぼ20%を占める加水分解性タンニンの次は、他の未同定化合物である。続いて、アントシアニン、イソフラボノイド、テルペノイド及びジテルペンが存在する。スマック果実の化学的性質の分析は、熟した果実について行われ、2.6%のタンパク質含有量、7.4%の脂肪含有量、14.6%の繊維含有量、1.8%の灰分を見出した。また、熱量計算では、100gのスマック果実が147.8kcalを含むことが示された。
温度制御機能を有するマイクロ波支援抽出システム、並びに他の抽出方法、ソックスレー及び従来の固体/液体抽出を含む様々な方法を使用することができる。
ニゲラ・アルベンシス(Nigella arvensis)
ニゲラ・カルパタ(Nigella carpatha)
ニゲラ・ダマシナ(Nigella damascena)
ニゲラ・デゲニイ(Nigella degenii)
ニゲラ・デセルティ(Nigella deserti)
ニゲラ・ドエルフレリ(Nigella doerfleri)
ニゲラ・エラタ(Nigella elata)
ニゲラ・フマリイフォラ(Nigella fumariifola)
ニゲラ・ヒスパニカ(Nigella hispanica)
ニゲラ・ラチセクタ(Nigella latisecta)
ニゲラ・ニゲラストルム(Nigella nigellastrum)
ニゲラ・オリエンタリス(Nigella orientalis)
ニゲラ・オキシペタラ(Nigella oxypetala)
ニゲラ・パピロサ(Nigella papillosa)
ニゲラ・サティバ(Nigella sativa)
ニゲラ・セゲタリス(Nigella segetalis)
ニゲラ・ストリクタ(Nigella stricta)
ニゲラ・ウングイクラリス(Nigella unguicularis)
モナルダ・フィスツロス(Monarda fistulos)(モナルダ(Monarda)属の);
サツレジャ・モンタナ(Satureja montana)(サツジェラ(Satujera)属の);
キク科(Asteraceae) - 例としては、以下の亜科が挙げられるが、これらに限定されない:
・ バルナデシオイデアエ(Barnadesioideae)Bremer & Jansen
・ カルディオイデアエ・スウィート(Carduoideae sweet)
・ シコリオイデアエ(Cichorioideae)Chevallier
・ コリムビオイデアエ(Corymbioideae)Panero & Funk
・ ファマチナントイデアエ(Famatinanthoideae)S.E.Freire,Ariza & Panero
・ ゴクナチオイデアエ(Gochnatioideae)Panero & Funk
・ ギムナルヘノイデアエ(Gymnarrhenoideae)Panero & Funk
・ ヘカストクレイドイデアエ(Hecastocleidoideae)Panero & Funk
・ ムチシオイデアエ(Mutisioideae)Lindley
・ ペルチオイデアエ(Pertyoideae)Panero & Funk
・ スチフチオイデアエ(Stifftioideae)Panero
・ ウンデルリキオイデアエ(Wunderlichioideae)Panero & Funk
ヒノキ科(Cupressaceae)
・ コウヨウザン(Cunninghamioideae)
・ タイワンスギ(Taiwanioideae)
・ アスロタキシス(Athrotaxidoideae)
・ アメリカスギ(Sequoioideae)
・ タキソジオイデアエ(Taxodioideae)
・ カリトロイデアエ(Callitroideae)
・ クプレッソイデアエ(Cupressoideae)
・ インケルタエ・セディス(Incertae sedis)
シソ科(Lamiacea)
キンポウゲ科(Ranunculacea)
・ ヒドラスチドイデアエ(Hydrastidoideae)
・ グラウシジオイデアエ(Glaucidioideae)
・ コプトイデアエ(Coptoideae)
・ タリクロイデアエ(Thalictroideae)
・ ラヌンクロイデアエ(Ranunculoideae)
モナルダ・ジジマ(Monarda didyma)
ニゲラ・サティバ(Nigella sativa)
オリガヌム・コンパクツム(Origanum compactum)
オリガヌム・ジクタムヌス(Origanum dictamnus)
オリガヌム・ミクロフィルム(Origanum microphyllum)
オリガヌム・オニテス(Origanum onites)
オリガヌム・スカブルム(Origanum scabrum)
オリガヌム・シリアクム(Origanum syriacum)
オリガヌム・ブルガレ(Origanum vulgare)
プレクトランスス・アンボイニクス(Plectranthus amboinicus)
チムス・グランズロスス(Thymus glandulosus)
ラバンデュラ・モルチフィダ(Lavandula multifida)
オリガヌム・ミヌチフロルム(Origanum minutiflorum)
サツレジャ・シンブラ(Satureja thymbra)
チムス・アダモビシイ(Thymus adamovicii)
チムス・アルタイクス(Thymus altaicus)
チムス・アムレンシス(Thymus amurensis)
チムス・ボイシエリ(Thymus boissieri)
チムス・ブラクテオスス(Thymus bracteosus)
チムス・ブロウソネチイ(Thymus broussonetii)
チムス・カエスピチチウス(Thymus caespititius)
チムス・カンフォラツス(Thymus camphoratus)
チムス・カピタツス(Thymus capitatus)
チムス・カピテラツス(Thymus capitellatus)
チムス・カンフォラツス(Thymus camphoratus)
チムス・カルノスス(Thymus carnosus)
チムス・セファロツス(Thymus cephalotus)
チムス・シェルレリオイデス(Thymus cherlerioides)
チムス・シリアツス(Thymus ciliatus)
チムス・シリシクス(Thymus cilicicus)
チムス・シミシヌス(Thymus cimicinus)
チムス・シトリオドルス(Thymus citriodorus)チムス×シトリオドルス(Thymus × citriodorus)syn.T.フラグランチシムス(T.fragrantissimus),T.セルピルム(T.serpyllum citratus),T.セルピルム・シトリオドルム(T.serpyllum citriodorum.)[7] - シトラスタイム
チムス・コモスス(Thymus comosus)
チムス・コンプツス(Thymus comptus)
チムス・クルツス(Thymus curtus)
チムス・デックサツス(Thymus decussatus)
チムス・ジスジュンクツス(Thymus disjunctus)
チムス・ドエルフレリ(Thymus doerfleri)
チムス・グラブレセンス(Thymus glabrescens)
チムス・ヘルバーバロナ(Thymus herba-barona)
チムス・ヒルスツス(Thymus hirsutus)
チムス・ヒエマリス(Thymus hyemalis)
チムス・イナエカリス(Thymus inaequalis)
チムス・インテゲル(Thymus integer)
チムス・ラヌギノスス(Thymus lanuginosus),syn.T.セルピルム(T.serpyllum)-ウーリー(woolly)タイム
チムス・ロイコスペルムス(Thymus leucospermus)
チムス・ロイコトリクス(Thymus leucotrichus)
チムス・ロンギカウリス(Thymus longicaulis)
チムス・ロンギフロルス(Thymus longiflorus)
チムス・マンドシュリクス(Thymus mandschuricus)
チムス・マルシャリアヌス(Thymus marschallianus)
チムス・マスチキナ(Thymus mastichina)
チムス・メンブラナセウス(Thymus membranaceus)
チムス・モンゴリクス(Thymus mongolicus)
チムス・モロデリ(Thymus moroderi)
チムス・ネルブロスス(Thymus nervulosus)
チムス・ヌムラリス(Thymus nummularis)
チムス・オドラチシムス(Thymus odoratissimus)
チムス・パラシアヌス(Thymus pallasianus)
チムス・パリズス(Thymus pallidus)
チムス・パノニクス(Thymus pannonicus)
チムス・プラエコックス(Thymus praecox)-クリーピングタイム
チムス・プロキシヌス(Thymus proximus)
チムス・シュードラヌギノスス(Thymus pseudolanuginosus),syn.T.セルピルム(T.serpyllum) - ウーリータイム
チムス・プレギオイデス(Thymus pulegioides)-レモンタイム [8]
チムス・キノケコスタツス(Thymus quinquecostatus)
チムス・リカルジイ(Thymus richardii)
チムス・サツレイオイデス(Thymus satureioides)
チムス・セルピルム(Thymus serpyllum)
チムス・シブトルピイ(Thymus sibthorpii)
チムス・ストリアツス(Thymus striatus)
チムス・トラシクス(Thymus thracicus)-ラベンダータイム
チムス・ビロスス(Thymus villosus)
チムス・ブルガリス(Thymus vulgaris)-コモンタイム
チムス・ジギス(Thymus zygis)
アイブライト(Euphrasia rostkoviana)
ラゴエシア・クミノイデス(Lagoecia cuminoides)
タイマツバナ(Monarda didyma)
ヤグルマハッカ(Monarda fistulosa)
モスラ・キネンシス(Mosla chinensis),Xiang Ru
オリガヌム・コンパクツム(Origanum compactum)
オリガヌム・ジクタムヌス(Origanum dictamnus)
オリガヌム・オニテス(Origanum onites)
オリガヌム・ブルガレ(Origanum vulgare)
サツレジャ・シンブラ(Satureja thymbra)
シムス・グランデュロスス(Thymus glandulosus)
シムス・ヒエマリス(Thymus hyemalis)
シムス・ブルガリス(Thymus vulgaris)
シムス・ジギス(Thymus zygis)
アジョワン(Trachyspermum ammi)
2009年4月にレバノンで無作為にS.シンブラ(S.thymbra)から空気乾燥した空気中部品を収集した。3時間、クレベンジャー型装置を用いて植物材料を水蒸気蒸留に供して、精油を収率0.84%(w/w)で製造した。無水硫酸マグネシウムを用いて油を乾燥し、4℃で保存した。S.シンブラ(S.thymbra)油をGC/MSで分析する。油サンプルの98.8%に相当する19の化合物が同定される。サツジェラ・シンブラ(Satujera thymbra)L.油の主成分は、γ-テルピネン(34.06%)、カルバクロール(23.07%)及びチモール(18.82%)である。また、ρ-シメン(7.58%)、カリオフィレン(3.96%)、α-テルピネン(3.53%)及びミルセン(1.70%)も豊富である。
サツレジャ・アダモビシイ(Satureja adamovicii)Silic - バルカン半島諸国
サツレジャ・アインタベンシス(Satureja aintabensis)P.H.Davis - トルコ
サツレジャ・アマニ(Satureja amani)P.H.Davis - トルコ
サツレジャ・アトロパタナ(Satureja atropatana)Bunge - イラン
サツレジャ・アブロマニカ(Satureja avromanica)Maroofi - イラン
サツレジャ・バクチアリカ(Satureja bachtiarica)Bunge - イラン
サツレジャ・ボイシエリ(Satureja boissieri)Hausskn.ex Boiss.- トルコ、イラン
サツレジャ・ブジビカ(Satureja bzybica)Woronow) - コーカサス
サツレジャ×カロリ-パウイ(Satureja × caroli-paui)G.Lopez) - スペイン(S.イノタ(S.innota)× S.モンタナ(S.montana))
サツレジャ・シリシカ(Satureja cilicica)P.H.Davis - トルコ
サツレジャ・コエルレア(Satureja coerulea)Janka - ブルガリア、ルーマニア、トルコ
サツレジャ・クネイフォリア(Satureja cuneifolia)Ten) - スペイン、イタリア、ギリシャ、アルバニア、ユーゴスラビア、イラク
サツレジャ×デルポゾイ(Satureja × delpozoi)Sanchez-Gomez,J.F.Jimenez & R.Morales - スペイン(S.クネイフォリア(S.cuneifolia)× S.イントリカタvar.グラシリス(S.intricata var.gracilis))
サツレジャ・エドモンジイ(Satureja edmondii)Briq.- イラン
サツレジャ×エクスペクタタ(Satureja × exspectata)G.Lopez - スペイン(S.イントリカタvar.グラシリス×S.モンタナ(S.intricata var.gracilis × S.montana))
サツレジャ・フカレキイ(Satureja fukarekii)Silic) - ユーゴスラビア
サツレジャ・ヘレニカ(Satureja hellenica)Halacsy - ギリシャ
サツレジャ・ホルテンシス(Satureja hortensis)L.
サツレジャ・ホルバチイ(Satureja horvatii)Silic - ギリシャ、ユーゴスラビア
サツレジャ・イカリカ(Satureja icarica)P.H.Davis - ギリシャの島々
サツレジャ・イノタ(Satureja innota)(Pau)Font Quer) - スペイン
サツレジャ・インテルメディア(Satureja intermedia)C.A.Mey.- イラン、コーカサス
サツレジャ・イントリカタ(Satureja intricata)Lange - スペイン
サツレジャ・イソフィラ(Satureja isophylla)Rech.f.- イラン
サツレジャ・カラリカ(Satureja kallarica)Jamzad - イラン
サツレジャ・ケルマンシャヘンシス(Satureja kermanshahensis)Jamzad - イラン
サツレジャ・クジスタニカ(Satureja khuzistanica)Jamzad) - イラン
サツレジャ・キタイベリ(Satureja kitaibelii)Wierzb.ex Heuff.- ブルガリア、ルーマニア、ユーゴスラビア
サツレジャ・ラキシフロラ(Satureja laxiflora)K.Koch - イラン、イラク、トルコ、コーカサス
サツレジャ・リネアリフォリア(Satureja linearifolia)(Brullo & Furnari)Greuter - リビアのキレナイカ地方
サツレジャ・マクランタ(Satureja macrantha)C.A.Mey.- イラン、イラク,トルコ、コーカサス
サツレジャ・メタスタシアンタ(Satureja metastasiantha)Rech.f.- イラク
サツレジャ・モンタナ(Satureja montana)L.- ウインターサボリー(winter savory) - 南ヨーロッパ、トルコ、シリア
サツレジャ・ムチカ(Satureja mutica)Fisch.& C.A.Mey.- コーカサス、イラン、トルクメニスタン
サツレジャ・ナバテオルム(Satureja nabateorum)Danin & Hedge - ヨルダン
サツレジャ×オレジェニイ(Satureja × orjenii)Silic - ユーゴスラビア(S.ホルバチイ(S.horvatii)×S.モンタナ(S.montana))
サツレジャ・パラリイ(Satureja pallaryi)J.Thiebaut - シリア
サツレジャ・パルナシカ(Satureja parnassica)Heldr.& Sart.ex Boiss.- ギリシャ,トルコ
サツレジャ・ピロサ(Satureja pilosa)Velen.- イタリア、ギリシャ、ブルガリア
サツレジャ・ルメリカ”(Satureja rumelica”)Velen.- ブルガリア
サツレジャ・サヘンジカ(Satureja sahendica)Bornm.- イラン
サツレジャ・サルツマンニイ(Satureja salzmannii)(Kuntze)P.W.Ball - モロッコ、スペイン
サツレジャ・スピシゲラ(Satureja spicigera)(K.Koch)Boiss.- トルコ、イラン、コーカサス
サツレジャ・スピノサ(Satureja spinosa)L.-トルコ、クレタ島を含むギリシャの島々
サツレジャ・スブスピカタ(Satureja subspicata)Bartl.ex Vis.- オーストリア、ユーゴスラビア、アルバニア、ブルガリア、イタリア
サツレジャ・タウリカ(Satureja taurica)Velen.- クリミア半島
サツレジャ・シンブラ(Satureja thymbra)L.- リビア、サルジニア島からトルコまでの南東ヨーロッパ;キプロス、レバノン、パレスチナ
サツレジャ・シンブリフォリア(Satureja thymbrifolia)Hedge & Feinbrun - イスラエル、サウジアラビア
サツレジャ・ビシアンニイ(Satureja visianii)Silic.- ユーゴスラビア
サツレジャ・ウィエデマンニアナ(Satureja wiedemanniana)(Ave-Lall.)Velen.) - トルコ
シンブラ・カロスタチヤ(Thymbra calostachya)Rech.f.- クレタ島
シンブラ・カピタタ(Thymbra capitata)(L.)Cav.) - モロッコ+ポルトガルからトルコ+パレスチナに広がる
シンブラ・シンテニシイ(Thymbra sintenisii)Bornm.& Azn.) - イラク、トルコ
シンブラ・スピカタ(Thymbra spicata)L.) - ギリシャ、トルコ、シリア、レバノン、パレスチナ、イスラエル、イラク、イラン
シンブラ・シンブリフォリア(Thymbra thymbrifolia)Hedge & Feinbrun Braeuchler,comb.nov.- イスラエル、パレスチナ、ユダヤ砂漠、キルベト・エル・ミルド(Khirbet el Mird)
シンブラ・ナバテオルム(Thymbra nabateorum)(Danin & Hedge)Braeuchler,comb.nov.- ヨルダンのW及びサウジアラビアの隣接N
シンブラ・リネアリフォリア(Thymbra linearifolia)(Brullo & Furnari)Braeuchler,comb.nov.- リビア
HPLC-MS方法を用いたスマックの化合物の特徴付け及び同定により、ルス・コリアリア(Rhus coriaria)中の191の化合物が同定され、一般的には以下のように分類された:
・ 78の加水分解性タンニン(例えば、ガロタンニン、例えば、ペンタ、ヘキサ、ヘプタ、オクタ、ノナ及びデカガロイル-グルコシド)
・ 59のフラボノイド(例えば、ケルセチン、ミレセチン3-ラムノシド及びケルセチン3-グルコシド)
・ 9つのアントシアニン(例えば、デルフィジン-3-グルコシド、シアニジン3-(2”-ガロイル)ガラクトシド、シアニジン-3-グルコシド、7-メチル-シアニジン-3-(2”ガロイル)ガラクトシド、7-メチル-シアニジン-3-ガラクトシド)
・ 2つのイソフラボノイド
・ 2つのテルペノイド
・ 1つのジテルペン
・ 38の他の未同定化合物。
アジア及び南ヨーロッパ
ルス・キネンシス(Rhus chinensis)Mill.- 中国スマック
ルス・コリアリア(Rhus coriaria) - タナーズ(Tanner’s)
ルス・デラバイ(Rhus delavayi)Franchet
オーストラリア、太平洋
ルス・タイテンシス(Rhus taitensis)Guill.(北西オーストラリア、マレーシア、ミクロネシア、フランス領ポリネシア)
ルス・サンドウィセンシス(Rhus sandwicensis)A.Gray - ネネロー(ハワイ)
北アメリカ
ルス・アロマチカ(Rhus aromatica) - 芳香スマック
ルス・コパリヌム(Rhus copallinum) - 翼のある又は輝くスマック
ルス・グラブラ(Rhus glabra) - 滑らかなスマック
ルス・インテグリフォリア(Rhus integrifolia) - レモネードスマック
ルス・ケアルネイ(Rhus kearneyi) - Kearneyスマック
ルス・ランセオラタ(Rhus lanceolata) - プレイリースマック
†ルス・マロリイ・ウォルフェ&ウェア(Rhus malloryiWolfe & Wehr) - ヤプレシアン、ワシントン
ルス・ミカウキシ(Rhus michauxii) - Michauxのスマック
ルス・ミクロフィラ(Rhus microphylla) - 砂漠スマック、小葉スマック
ルス・オバタ(Rhus ovata) - 糖スマック
†ルス・レプブリセンシス(Rhus republicensis)Flynn,DeVore,& Pigg) - ヤプレシアン、ワシントン
†ルス・ルーセアエ(Rhus rooseae)Manchester - 始新世中期、オレゴン
ルス・トリロバタ(Rhus trilobata)Nutt.- スカンクブッシュスマック
ルス・チフィナ(Rhus typhina) - スタグホーンスマック
ルス・ビレンス(Rhus virens)Lindh.exA.Gray - エバグリーンスマック
多様な方法を用いた人参の化学化合物の特徴付け及び同定は、オタネニンジン(Panax ginseng)において非常に様々な化合物を同定し、一般的に以下のように分類された:
・ サポニングリコシド(例えば、ギンセノシド)
・ フィトステロール(例えば、スチグマステロール、ベータ-ステロール)
・ セスキテルペン(例えば、ベータ-アラミン及びベータ-セリニン)
・ フラベノイド(例えば、ケンフェロール)
・ ポリアセチレン(例えば、パナキシノール、ギンセノインA)
・ アルカロイド(例えば、フマリン、ギリニムビン)
・ 多糖類
・ フェノール化合物(例えば、エレミシン、ダウリシン、マルトール)。
フランキンセンスとしても知られるオリバヌム(Olibanum)は、ボスウェリア(Boswellia)の樹皮のタッピングから滲出する天然オレオガム樹脂である。ボスウェリア(Boswellia)属には約23種の樹木があり、これらは主にアラビア、アフリカ東海岸、及びインドに生育している。多様な方法を用いたオリバヌム(Olibanum)の化合物の特徴付け及び同定により、ボスウェリア(Boswellia)樹木種のガム樹脂中の非常に様々な化合物が同定され、それらは一般的に以下のように分類された:
・ アルコール可溶性樹脂(例えば、ジテルペン、トリテルペン)
・ 高芳香性精油(例えば、モノ-及びセスキテルペン)
・ 水溶性ガム
・ 酸性樹脂(6%)、アルコールに可溶であり、式C20H32O4を有する
・ ガム(アラビアゴムに類似)30~36%
・ 3-アセチル-ベータ-ボスウェル酸(ボスウェリア・サクラ(Boswellia sacra))
・ アルファ-ボスウェル酸(ボスウェリア・サクラ(Boswellia sacra))
・ 酢酸インセンソール、C21H34O3
・ フェランドレン
アマチャヅル(Gynostemma pentaphyllum)は、中国、台湾、韓国、日本、タイ、ベトナム及びラオスを含む、北東及び東南アジアの多くの地域の山岳斜面上の森林、やぶ又は道端で生育するウリ科(Cucurbitaceae)の多年生草本であり、5葉の葉と、ひょうたん様の食用にならない果実を有する。アマチャヅル(G.pentphyllum)は、バングラデシュ、ブータン、インド、インドネシア、マレーシア、ミャンマー、ネパール、ニューギニア及びスリランカでも生育している。ジャオグラン(Jiaogulan)は、「長寿植物」として高く評価されている。多様な方法を用いたアマチャヅル(Gynostemma pentaphyllum)の化合物の特徴付け及び同定は、アマチャヅル(Gynostemma pentaphyllum)(Thum.)Makinoにおける非常に様々な化合物を同定し、それらを一般的に以下のように分類する:
・ サポニングリコシド(例えば、ギペノシド)
・ フェノール化合物
・ フラベノイド(例えば、ケンフェロール、ケルセチン、ルチン、オムブイン、イソラムネチン)
・ 多糖類
・ ステロール(例えば、エルゴスタン、コレスタン、スチグマスタン)
・ 微量元素(例えば、Cu、Fe、Zn、Mn、Co、Ni、Se、Mo及びSr)
・ カロテノイド
・ 揮発性物質(例えば、マロン酸、ベンジル-O-ベータ-D-グルコピラノシド、ルテイン、ボミフォリオール、パルミチン酸、リノール酸)
特定の実施形態によれば、この種の植物は、フラボン、モノテルペノイド及びモノテルペンを含む。60を超える異なる化合物が同定されており、主要な化合物は、カルバクロール及びチモールであり、80%を超える範囲であるが、より少量の化合物には、p-シメン、γ-テルピネン、カリオフィレン、スパツレノール、ゲルマクレン-D,β-フェンキルアルコール及びδ-テルピネオールが含まれる。
オリガヌム・アクチデンス(Origanum acutidens)Hand.-Mazz.)Ietsw.- トルコ、イラク
オリガヌム×アデネンセ(Origanum × adanense)Baser & H.Duman - トルコ(O.バルギリ(O.bargyli)×O.ラエビガツム(O.laevigatum))
オリガヌム×アドニジス(Origanum × adonidis)Mouterde- レバノン(O.リバノチクム(O.libanoticum)×O.シリアクム亜種ベバニイ(O.syriacumsubsp.bevanii))
オリガヌム・アクダレンセ(Origanum akhdarense)Ietsw.& Boulos - 東リビアのキレナイカ地域
オリガヌム・アマヌム(Origanum amanum)Post - トルコのハタイ地域
オリガヌム×バルバラエ(Origanum × barbarae)Bornm.- レバノン(O.エーレンベルジイ(O.ehrenbergii)× O.シリアクム亜種ベバニイ(O.syriacumsubsp.bevanii))
オリガヌム・バルギリ(Origanum bargyli)Mouterde - トルコ、シリア
オリガヌム・ビルゲリ(Origanum bilgeri)P.H.Davis - トルコのアンタルヤ地域
オリガヌム・ボイシエリ(Origanum boissieri)Ietsw.- トルコ
オリガヌム・カルカラツム(Origanum calcaratum)Juss.- ギリシャ
オリガヌム・コンパクツム(Origanum compactum)Benth.- スペイン、モロッコ
オリガヌム・コルジフォリウム(Origanum cordifolium)(Montbret & Aucher ex Benth.)Vogel - キプロス
オリガヌム・シレナイクム(Origanum cyrenaicum)Beg.& Vacc.- 東リビアのキレナイカ地域
オリガヌム・ダイイ(Origanum dayi)Post - イスラエル
オリガヌム・ジクタムヌス(Origanum dictamnus)L.- ホップマジョラム(hop marjoram)、クレタ島ディタニー(Cretan dittany)、クレタ島のディタニー(dittany of Crete) - クレタ島固有
オリガヌム・ドリコシフォン(Origanum × dolichosiphon)P.H.Davis - トルコのセイハン地域(O.amanum × O.laevigatum)
オリガヌム・エーレンベルジイ(Origanum ehrenbergii)Boiss.- レバノン
オリガヌム・エロンガツム(Origanum elongatum)(Bonnet) Emb.& Maire - モロッコ
オリガヌム・フロリブンヅム(Origanum floribundum)Munby - アルジェリア
オリガヌム×ハラジャニイ(Origanum × haradjanii)Rech.f - トルコ(O.ラエビガツム(O.laevigatum)×O.シリアクム亜種ベバニイ(O.syriacum subsp.bevanii)
オリガヌム・ハウスクネキチイ(Origanum haussknechtii)Boiss.) - トルコ
オリガヌム・フスヌカン-バセリ(Origanum husnucan-baseri)H.Duman,Aytac & A.Duran) - トルコ
オリガヌム・ヒペリシフォリウム(Origanum hypericifolium)O.Schwarz & P.H.Davis - トルコ
オリガヌム×インテルセデンス(Origanum × intercedens)Rech.f.- ギリシャ、トルコ(O.オニテス(O.onites) × O.ブルガレ亜種ヒルツム(O.vulgare subsp.hirtum))
オリガヌム×インテルメジウム(Origanum × intermedium)P.H.Davis - トルコのデニズリ(O.onites × O.sipyleum)
オリガヌム・イツミクム(Origanum isthmicum)Danin) - シナイ
オリガヌム・ジョルダニクム(Origanum jordanicum)Danin & Kunne - ヨルダン
オリガヌム・ラエビガツム(Origanum laevigatum)Boiss.- トルコ、シリア、キプロス
オリガヌム・レプトクラヅム(Origanum leptocladum)Boiss.- トルコ
オリガヌム・リバノチクム(Origanum libanoticum)Boiss.- レバノン
オリガヌム・マジョラナ(Origanum majorana)L.- (スイート)マジョラム - トルコ、キプロス;ヨーロッパ、北アフリカ、北+南アメリカに散在する場所に帰化
オリガヌム×リリウム(Origanum × lirium)Heldr.ex Halacsy - ギリシャ(O.スカブルム(O.scabrum) × O.ブルガレ亜種ヒルツム(O.vulgare subsp.hirtum))
オリガヌム×マジョリクム(Origanum × majoricum)Cambess.- ハーディースイートマジョラム - バレアレス諸島を含むスペイン(O.マジョラナ(O.majorana)×O.ブルガレ亜種ビレンス(O.vulgare subsp.virens))
オリガヌム・ミクロフィルム(Origanum microphyllum)(Benth.)Vogel - クレタ島
オリガヌム×ミノアヌム(Origanum × minoanum)P.H.Davis -クレタ島(O.ミクロフィルム(O.microphyllum) × O.ブルガレ亜種ヒルツム(O.vulgare subsp.hirtum))
オリガヌム・ミヌチフロルム(Origanum minutiflorum)O.Schwarz & P.H.Davis - トルコ
オリガヌム・ムンズレンセ(Origanum munzurense)Kit Tan & Sorger - トルコ
オリガヌム×ネブロデンセ(Origanum × nebrodense)Tineo ex Lojac - シチリア(O.マジョラナ(O.majorana)× O.ブルガレ亜種ビリヅルム(O.vulgare subsp.viridulum))
オリガヌム・オニテス(Origanum onites)L.- ギリシャ、トルコ、シチリア
オリガヌム×パボチイ(Origanum × pabotii)Mouterde - シリア(O.バルギリ(O.bargyli)× O.シリアクム亜種ベバニイ(O.syriacum subsp.bevanii))
オリガヌム・パムパニニイ(Origanum pampaninii)(Brullo & Furnari)Ietsw - 東リビアのキレナイカ地域
オリガヌム・ペトラエウム(Origanum petraeum)Danin - ヨルダン
オリガヌム・プノネンセ(Origanum punonense)Danin - ヨルダン
オリガヌム・ラモネンセ(Origanum ramonense)Danin - イスラエル
オリガヌム・ロツンジフォリウム(Origanum rotundifolium)Boiss.- トルコ、コーカサス
オリガヌム・サッカツム(Origanum saccatum)P.H.Davis - トルコ
オリガヌム・スカブルム(Origanum scabrum)Boiss.& Heldr.in P.E.Boissier - ギリシャ
オリガヌム・シピレウム(Origanum sipyleum)L.- トルコ、ギリシャの島々
オリガヌム・ソリミクム(Origanum solymicum)P.H.Davis - トルコのアンタルヤ地域
オリガヌム・シメス(Origanum symes)Carlstroem - エーゲ海の島々
オリガヌム・シリアクム(Origanum syriacum)L.- トルコ、キプロス、シリア、レバノン、ヨルダン、パレスチナ、イスラエル、シナイ、サウジアラビア
オリガヌム・ベッテリ(Origanum vetteri)Briq.& Barbey - クレタ島
オリガヌム・ボゲリイ(Origanum vogelii)Greuter & Burdet - トルコ
オリガヌム・ブルガレ(Origanum vulgare)L.- オレガノ- ヨーロッパ、北アフリカ、温帯アジア(イラン、シベリア、中央アジア、中国など);北アメリカ、ニュージーランド、ベネズエラの一部に帰化。
ゴマ種子は、テリグナン、セサモリン、セサミン、ピノレシノール及びラリシレシノールを含有する。不溶性11Sグロブリン及び可溶性2Sアルブミン(従来は、α-グロブリン及びβ-グロブリンと呼ばれていた)は、2つの主要な貯蔵タンパク質であり、ゴマの全種子タンパク質の80~90%を構成する。アミノ酸組成の比較は、それらが既知のオレオシンよりも実質的に疎水性が低く、したがって、オレオシンの凝集多量体であってはならないことを示した。ゴマタンパク質に対する免疫認識の結果は、これらの3つのポリペプチドが成熟種子における小器官の活性集合の間に、オレオシン及びトリアシルグリセロールを付随する油体に集められた独特のタンパク質であることを明らかにする。リン脂質、オレイン酸及びリノール酸、クロロフィル及びセサモリン、セサモール及びγ-トコフェロールが見出されている。10種の化合物[2-フルフリルチオール、2-フェニルエチルチオール、2-メトキシフェノール、4-ヒドロキシ2,5-ジメチル-3[2H]-フラノン、2-ペンチルピリジン、2-エチル-3,5-ジメチルピラジン、アセチルピラジン、[E,E]-2,4-デカジエナール、2-アセチル-1-ピロリン及び4-ビニル-2-メトキシ-フェノール]が定量されている。油中の高いOAV、特に2-アセチル-1-ピロリン[焙煎]に基づいて、2-フルフリルチオール[コーヒー様]、2-フェニルエチルチオール[ゴム状]及び4-ヒドロキシ-2,5-ジメチル3[2H]-フラノン[カラメル様]が、破砕ゴマ材料の焙煎、硫黄臭の全体に対する重要な寄与因子として解明されている。ゴマ種子から単離された新規なセサミノールグルコシドの構造は、セサミノール2’O-β-d-グルコピラノシド、セサミノール2’-O-β-d-グルコピラノシル[1→2]-O-β-dグルコピラノシド及びセサミノール2’-O-β-dグルコピラノシル[1>>2]-O-[β-d-グルコピランシル(glucopyransyl)[1>>6]]-[β-dグルコピラノシド]であると決定された。また、-(7S,8’R,8R)-アクミナトリドピペリトール及びピノレシノールのような微量のゴマリグナン(前述したように)。
セサムン・アブレビツム(Sesamum abbreviatum)Merxm.
セサムン・アラツム(Sesamum alatum)Thonn.
セサムン・アンゴレンセ(Sesamum angolense)Welw.
セサムン・ビアピキュラツム(Sesamum biapiculatum)De Wild.
セサムン・カリシヌム(Sesamum calycinum)Welw.
セサムン・カペンセ(Sesamum capense)Burm.f.
セサムン・ジギタロイデス(Sesamum digitaloides)Welw.ex Schinz
セサムン・グラシレ(Sesamum gracile)Endl.
セサムン・ホプキンシイ(Sesamum hopkinsii)Suess.
セサムン・インジクム(Sesamum indicum)L.
セサムン・ラミイフォリウム(Sesamum lamiifolium)Engl.
セサムン・ラチフォリウム(Sesamum latifolium)J.B.Gillett
セサムン・レピドツム(Sesamum lepidotum)Schinz
セサムン・マクランスム(Sesamum macranthum)Oliv.
セサムン・マルロチイ(Sesamum marlothii)Engl.
セサムン・ボムバゼンセ(Sesamum mombazense)De Wild.& T.Durand
セサムン・パルビフロルム(Sesamum parviflorum)Seidenst.
セサムン・ペダリオイデス(Sesamum pedalioides)Welw.ex Hiern
セサムン・ラジアツム(Sesamum radiatum)Schumach.& Thonn.
セサムン・リジヅム(Sesamum rigidum)Peyr.
セサムン・ロストラツム(Sesamum rostratum)Hochst.
セサムン・サブロスム(Sesamum sabulosum)A.Chev.
セサムン・シンジアヌム(Sesamum schinzianum)Asch.
セサムン・ソマレンス(Sesamum somalense)Chiov.
セサムン・トンネリ(Sesamum thonneri)De Wild.& T.Durand
セサムン・トリフィルム(Sesamum triphyllum)Welw.ex Asch.
ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、サツレジャ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)及びルス・コリアリア(Rhus coriaria)。
ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、シンブラ・スピカタ(Thymbra spicata)、サツレジャ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)及びルス・コリアリア(Rhus coriaria)。
ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、サツレジャ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)及びルス・コリアリア(Rhus coriaria)。
ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、セサムン・インジクム(Sesamum indicum)及びルス・コリアリア(Rhus coriaria)。
ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、サツレジャ・シンブラ(Satujera thymbra)、及びルス・コリアリア(Rhus coriaria)。
ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、サツレジャ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)。
ニゲラ・サティバ(Nigella sativa)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、サツレジャ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)及びルス・コリアリア(Rhus coriaria)。
ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、サツレジャ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)及びルス・コリアリア(Rhus coriaria)。
ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、セサムン・インジクム(Sesamum indicum)及びルス・コリアリア(Rhus coriaria)。
ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、及びルス・コリアリア(Rhus coriaria)。
ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、サツレジャ・シンブラ(Satujera thymbra)。
ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)。
ニゲラ・サティバ(Nigella sativa)、チムス・ブルガリス(Thymus vulgaris)。
ニゲラ・サティバ(Nigella sativa)、オリガヌム・シリアクム(Origanum syriacum)。
ニゲラ・サティバ(Nigella sativa)、シンブラ・スピカタ(Thymbra spicata)。
ニゲラ・サティバ(Nigella sativa)、サツレジャ・シンブラ(Satujera thymbra)。
ニゲラ・サティバ(Nigella sativa)、セサムン・インジクム(Sesamum indicum)。
ニゲラ・サティバ(Nigella sativa)、ルス・コリアリア(Rhus coriaria)
が含まれるが、これらに限定されない。
ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)。
ニゲラ・サティバ(Nigella sativa)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)。
ニゲラ・サティバ(Nigella sativa)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)。
ニゲラ・サティバ(Nigella sativa)、シンブラ・スピカタ(Thymbra spicata)、サツジェラ・シンブラ(Satujera thymbra)。
ニゲラ・サティバ(Nigella sativa)、サツジェラ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)、ルス・コリアリア(Rhus coriaria)。
NMRDの改善に関するアッセイ
伝統的なインビボ動物モデルに加えて、NMRDを含む状態を評価するための多くの細胞ベースのインビトロ系が利用可能である。NMRDをモデリングするために、気道関連の細胞、例えば胸膜中皮細胞(PMC)、小気道上皮細胞(SAEC)、気管支上皮細胞(BEC)、鼻上皮細胞、及び気管支線維芽細胞の初代及び細胞株を培養し、化学/病原性侵襲に曝露する。細胞応答、並びに特に炎症プロセス、老化及び細胞活性化を、添加された本発明の組成物及び/又は成分の存在又は非存在下で決定して、本発明の組成物及び/又は成分が、細胞に対する侵襲の効果を低減し又は別様に改変する能力を評価する。細胞は、2-D又は3-D培養において増殖することができる。
NMRDの動物モデルは、呼吸器疾患及び状態の誘導動物モデル及び天然に存在する動物モデルを含む。
COPD:げっ歯類、煙草の煙への暴露、血管壁及び気道リモデリングの評価;
肺気腫:げっ歯類、エラスチン分解エラスターゼへの暴露、コラゲナーゼのトランスジェニック過剰発現;
下部呼吸器感染症:げっ歯類、共生、エアロゾル化、ネブライザー、直接的な気道導入;
肺線維症:げっ歯類、環境曝露(珪肺症、石綿肺、アレルゲン、ブレオマイシン誘導、次亜塩素酸HOCl、ハプテン誘導肺線維症;
喘息:げっ歯類、アレルゲンによる反復チャレンジ(杯細胞過形成、気道炎症及び応答性亢進をもたらす(リモデリング)、イエダニへの暴露。
植物成分によるSARS-CoV-2の改善に関するアッセイ
COVID-19は、重症急性呼吸器症候群コロナウイルス2(SARS-CoV-2)によって引き起こされる。細胞膜ACE-2受容体は、SARS-CoV-2の付着及び侵入部位である。ACE-2受容体は、ACEと相同性を有するI型膜貫通メタロカルボキシペプチダーゼであり、これはレニン-アンギオテンシン系(RAS)において重要な役割を果たすことが長く知られている酵素であり、高血圧の処置のための標的である。SARS-CoV-2が細胞侵入受容体としてACE-2を利用するという証拠がある。Zhouらは、SARS-CoV-2がヒト、中国馬蹄形コウモリ、ジャコウネコ、及び豚からのACE-2を用いてACE-2発現HeLa細胞に侵入できることを示した(Zhou,P.,Yang,XL.,Wang,XG.et al.A pneumonia outbreak associated with a new coronavirus of probable bat origin.Nature 579,270-273(2020)参照)。受容体認識及び細胞膜融合プロセスにおいて重要な役割を果たすSARS-CoV-2のスパイク(S)タンパク質は、2つのサブユニット、S1(120kDa)及びS2(80kDa)から構成される。S1サブユニットは、宿主受容体アンギオテンシン変換酵素2(ACE-2)を認識し、それに結合する受容体結合ドメインを含む。S2サブユニットは、2ヘプタド反復ドメインを介して6ヘリカル束を形成することにより、ウィル細胞膜融合を媒介する(Huang,Y.,Yang,C.,Xu,Xf.et al.Structural and functional properties of SARS-CoV-2 spike protein:potential antivirus drug development for COVID-19.Acta Pharmacol Sin 41,1141-1149(2020)参照)。S1及びS2サブユニットの機能を妨害し、減弱し、損なうことは、最終的には、減弱され、損なわれ、感染性の低いウイルスをもたらすであろう。
以下のウイルスタンパク質消化アッセイの全てに使用した材料を、表1に開示する。
品目1+2+3+4(複合体B)からの等しい体積から調製された混合物とタンパク質をインキュベートした後、タンパク質シグナルの26%の減少が観察された。
組換えSARS-Cov-2 S2サブユニットタンパク質
品目1+2+3+4(複合体B)からの等しい体積から調製された混合物とタンパク質をインキュベートした後、タンパク質シグナルの19%の減少が観察された。
品目1+2+3+4+5(複合体C)からの等しい体積から調製された混合物とタンパク質をインキュベートした後、タンパク質シグナルの27%の減少が観察された
品目1+2+3+4+5+6(複合体D)からの等しい体積から調製された混合物とタンパク質をインキュベートした後、タンパク質シグナルの47%の減少が観察された。
Claims (23)
- 対象におけるウイルス侵入機構タンパク質を修飾することにより、非悪性呼吸器疾患(NMRD)ウイルスの感染性を低下させる方法であって、植物部分、その抽出物、その画分、その活性成分、その合成類似体、その模倣物又はそれらの組み合わせからなる群から選択される植物種又はその属由来成分の有効量を前記対象に投与することを含み、前記成分はNMRDの症状を改善することができ、前記植物種は、ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、サツジェラ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)、ルス・コリアリア(Rhus coriaria)、アマチャヅル(Gynostemma pentaphyllum)、ボスウェリア・サクラ(Boswellia sacra)及びオタネニンジン(Panax ginseng)からなる群から選択される、方法。
- 対象におけるウイルス侵入機構タンパク質を修飾することにより、ウイルスの感染性を低下させる方法であって、前記ウイルスは、表Aの非限定的なリストから選択され、前記方法は、植物部分、その抽出物、その画分、その活性成分、その合成類似体、その模倣物又はそれらの組み合わせからなる群から選択される植物種又はその属由来成分の有効量を前記対象に投与することを含み、前記成分は、表Aの非限定的なリストから選択される前記ウイルスの症状を改善することができ、前記植物種は、ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、サツジェラ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)、ルス・コリアリア(Rhus coriaria)、アマチャヅル(Gynostemma pentaphyllum)、ボスウェリア・サクラ(Boswellia sacra)及びオタネニンジン(Panax ginseng)からなる群から選択される、方法。
- 非悪性呼吸器疾患(NMRD)の予防又は処置を必要とする対象において非悪性呼吸器疾患(NMRD)を予防又は処置する方法であって、植物部分、その抽出物、その画分、その活性成分、その合成類似体、その模倣物又はそれらの組み合わせからなる群から選択される植物種又はその属由来成分の有効量を前記対象に投与することであって、前記成分はNMRDの症状を改善することができ、前記植物種は、ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、サツジェラ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)、ルス・コリアリア(Rhus coriaria)、アマチャヅル(Gynostemma pentaphyllum)、ボスウェリア・サクラ(Boswellia sacra)及びオタネニンジン(Panax ginseng)からなる群から選択される、投与することと、前記対象においてNMRDを予防又は処置することと、を含む、方法。
- 植物部分、その抽出物、その画分、その活性成分、その合成類似体、その模倣物、又はそれらの組み合わせからなる群から選択される植物種又はその属由来成分の有効量を含む、NMRDに対するワクチンであって、前記成分はNMRDの症状を改善することができ、前記植物種は、ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、サツジェラ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)、ルス・コリアリア(Rhus coriaria)、アマチャヅル(Gynostemma pentaphyllum)、ボスウェリア・サクラ(Boswellia sacra)、及びオタネニンジン(Panax ginseng)からなる群から選択される、ワクチン。
- NMRDの予防又は処置に使用するための、植物部分、その抽出物、その画分、その活性成分、その合成類似体、その模倣物、又はそれらの組み合わせからなる群から選択される植物種又はその属由来成分の有効量を含む医薬組成物であって、前記成分はNMRDの症状を改善することができ、前記植物種は、ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、サツジェラ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)、ルス・コリアリア(Rhus coriaria)、アマチャヅル(Gynostemma pentaphyllum)、ボスウェリア・サクラ(Boswellia sacra)、及びオタネニンジン(Panax ginseng)からなる群から選択される、医薬組成物。
- 植物部分、その抽出物、その画分、その活性成分、その合成類似体、その模倣物、又はそれらの組み合わせからなる群から選択される植物種又はその属由来成分のうちの少なくとも2つを含む組成物であって、前記成分はNMRDの症状を改善することができ、前記植物種は、ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、サツジェラ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)、ルス・コリアリア(Rhus coriaria)、アマチャヅル(Gynostemma pentaphyllum)、ボスウェリア・サクラ(Boswellia sacra)及びオタネニンジン(Panax ginseng)からなる群から選択される、組成物。
- 植物部分、その抽出物、その画分、その活性成分、その合成類似体、その模倣物、又はそれらの組み合わせからなる群から選択される植物種又はその属由来成分のうちの少なくとも2つの組み合わせを含む食品サプリメントであって、前記成分はNMRDの症状を改善することができ、前記植物種は、ニゲラ・サティバ(Nigella sativa)、チムス・カピタツス(Thymus capitatus)、チムス・ブルガリス(Thymus vulgaris)、オリガヌム・シリアクム(Origanum syriacum)、シンブラ・スピカタ(Thymbra spicata)、サツジェラ・シンブラ(Satujera thymbra)、セサムン・インジクム(Sesamum indicum)、ルス・コリアリア(Rhus coriaria)、アマチャヅル(Gynostemma pentaphyllum)、ボスウェリア・サクラ(Boswellia sacra)、及びオタネニンジン(Panax ginseng)からなる群から選択される、食品サプリメント。
- 前記NMRDが、肺高血圧症、間質性肺疾患、急性肺損傷(ALI)、急性呼吸促迫症候群(ARDS)、肺のサルコイドーシス、気管支拡張症、石綿肺、ベリリウム症、珪肺症、炭粉症、組織球症X、肺炎、喫煙者の肺、閉塞性細気管支炎、結核及び肺線維症による肺の瘢痕化、慢性閉塞性肺疾患、じん肺症、外傷性肺損傷、肺感染症並びに全身性エリテマトーデス、関節リウマチ、強皮症、多発性筋炎及び皮膚筋炎を含む結合組織疾患の肺症状の群から選択される、請求項1、3~7のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- 前記NMRDが、慢性閉塞性肺疾患(COPD)、特発性肺線維症(IPF)又は喘息である、請求項1、3~7のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- 前記症状が、咳、息切れ、喘鳴、呼吸困難、気道の炎症、胸部絞扼感及び運動不耐性からなる群から選択される、請求項1、3~7のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- 前記成分が少なくとも2つの成分を含む、請求項1~7のいずれか1項に記載の方法、ワクチン、医薬組成物。
- 前記成分が少なくとも3つの成分を含む、請求項1~7のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- 前記成分が少なくとも4つの成分を含む、請求項1~7のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- 前記成分が少なくとも5つの成分を含む、請求項1~7のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- 前記成分が5~10個の成分を含む、請求項1~7のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- 前記成分がチモキノン又はその類似体を含む、請求項1~7、11~15のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- 前記成分がチモール又はその類似体を含む、請求項1~7、11~15のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- 前記成分がカルバクロール又はその類似体を含む、請求項1~7、11~15のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- 前記成分がブロメライン又はその類似体を含む、請求項1~7、11~15のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- 前記成分が、ブロメライン又はその類似体を含むパイナップル抽出物を含む、請求項1~7、11~15のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- 前記成分が、トリプトファン、その類似体、又はトリプトファンを含有する植物の抽出物を含む、請求項1~7、11~15のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント。
- ローズ・リーブス・ミクロメリア・フルティコーサ、サルビア、シンボポゴン(シトラール、)アロイシア、クマツヅラ(verbena officinalis)、マジョラム(origanum majorana)、ハッカ(menthe)を含む「ベデュイン茶」をさらに含む、請求項1~7、11~15のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物又は食品サプリメント、組成物又は抽出物。
- タイム、セージ、カルダモン、シナモン、紅茶、ハブク、マルマヤを含む「ベデュイン茶」をさらに含む、請求項1~7、11~15のいずれか1項に記載の方法、ワクチン、医薬組成物、組成物、又は食品サプリメント。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062992276P | 2020-03-20 | 2020-03-20 | |
US62/992,276 | 2020-03-20 | ||
PCT/IL2021/050308 WO2021186454A1 (en) | 2020-03-20 | 2021-03-19 | Compositions and methods for treating and preventing non-malignant respiratory disease |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2023522298A true JP2023522298A (ja) | 2023-05-30 |
Family
ID=77768409
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022557079A Pending JP2023522298A (ja) | 2020-03-20 | 2021-03-19 | 非悪性呼吸器疾患を処置及び予防するための組成物及び方法 |
JP2022557078A Pending JP2023522297A (ja) | 2020-03-20 | 2021-03-19 | コロナウイルス感染症を処置及び予防するための組成物及び方法 |
JP2022557081A Pending JP2023522299A (ja) | 2020-03-20 | 2021-03-19 | 固形及び軟部腫瘍並びに増殖性疾患を処置するための組成物及び方法 |
JP2022557080A Pending JP2023526724A (ja) | 2020-03-20 | 2021-03-19 | 糖尿病i型及びii型並びに甲状腺疾患を含む炎症性疾患を処置又は予防するための組成物及び方法 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022557078A Pending JP2023522297A (ja) | 2020-03-20 | 2021-03-19 | コロナウイルス感染症を処置及び予防するための組成物及び方法 |
JP2022557081A Pending JP2023522299A (ja) | 2020-03-20 | 2021-03-19 | 固形及び軟部腫瘍並びに増殖性疾患を処置するための組成物及び方法 |
JP2022557080A Pending JP2023526724A (ja) | 2020-03-20 | 2021-03-19 | 糖尿病i型及びii型並びに甲状腺疾患を含む炎症性疾患を処置又は予防するための組成物及び方法 |
Country Status (13)
Country | Link |
---|---|
US (4) | US20230346866A1 (ja) |
EP (4) | EP4121077A4 (ja) |
JP (4) | JP2023522298A (ja) |
KR (4) | KR20230005128A (ja) |
CN (4) | CN115666540A (ja) |
AU (4) | AU2021239186A1 (ja) |
BR (4) | BR112022018645A2 (ja) |
CA (4) | CA3175442A1 (ja) |
CO (4) | CO2022013172A2 (ja) |
IL (4) | IL296407A (ja) |
MX (4) | MX2022011572A (ja) |
WO (4) | WO2021186456A1 (ja) |
ZA (4) | ZA202210080B (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102445444B1 (ko) * | 2021-12-09 | 2022-09-22 | 주식회사 나투어바이오제약 | 안전성을 기반으로 한 고함량의 기능성 성분을 포함하는 발효흑삼 제조 개선 방법 |
CN115651088A (zh) * | 2022-08-23 | 2023-01-31 | 辽宁成大生物股份有限公司 | 人参总多糖的制备方法和应用、人参总多糖疫苗佐剂及其疫苗组合物 |
CN116036262A (zh) * | 2022-08-23 | 2023-05-02 | 沈阳药科大学 | 一种人参酸性多糖疫苗佐剂、疫苗组合物及其应用 |
CN115501333A (zh) * | 2022-09-27 | 2022-12-23 | 沈阳药科大学 | 一种疫苗佐剂、疫苗组合物及其应用 |
CN117462539A (zh) * | 2023-12-26 | 2024-01-30 | 云南中医药大学 | 一种二氢黄酮醇型化合物的抗冠状病毒用途及制备方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1054514C (zh) * | 1992-05-11 | 2000-07-19 | 卜荣安 | 绞股兰复合保健茶的制作工艺 |
JP4651756B2 (ja) * | 1997-02-25 | 2011-03-16 | サランティス プロプライエタリィ リミテッド | ブロメラインの成分である単離されたタンパク質、同タンパク質を含む治療剤及び製薬組成物 |
US9072753B1 (en) * | 2000-04-03 | 2015-07-07 | Amy C. Brown | Gargle method to reduce the duration of common cold symptoms |
WO2002080951A1 (en) * | 2001-04-06 | 2002-10-17 | Synergistix Biotech, Inc. | Herbal extracts for the treatment of cancer |
US8029831B2 (en) * | 2008-07-29 | 2011-10-04 | Bionexus, Ltd. | Formulations containing thymoquinone for urinary health |
CA2626049A1 (en) * | 2004-10-15 | 2006-04-20 | Biopharmacopae Design International Inc. | Methods and therapeutic compositions comprising plant extracts for the treatment of cancer |
CN101227916A (zh) * | 2005-05-24 | 2008-07-23 | 维尔金有限公司 | 预防和治疗发炎相关状况的组合物和方法 |
US20080038367A1 (en) * | 2006-08-11 | 2008-02-14 | Sal Saloum | Nutritional supplement compositions and methods of preparing |
US20110086052A1 (en) * | 2008-02-29 | 2011-04-14 | Adamko Darryl J | Activation of innate and adaptive immune responses by a ginseng extract |
CN102264364B (zh) * | 2008-10-22 | 2014-06-18 | 康奈尔大学 | 一种多环化合物及其相关方法 |
US20100119558A1 (en) * | 2008-11-10 | 2010-05-13 | Scandivir Ab | Ngna compositions and methods of use |
GB0917086D0 (en) * | 2009-09-29 | 2009-11-11 | Union Of Agricultural Cooperat | Compositon of botanical extracts and their use |
US8734859B1 (en) * | 2010-11-13 | 2014-05-27 | Sirbal Ltd. | Molecular combinations for cancer or other disease treatment |
US20130344215A1 (en) * | 2012-06-26 | 2013-12-26 | Yl Holdings, Inc. | Weight loss beverage |
WO2016014699A1 (en) * | 2014-07-22 | 2016-01-28 | Ralco Nutrition, Inc. | Antiviral compositions and methods |
WO2016051220A1 (en) * | 2014-09-30 | 2016-04-07 | Umm Al-Qura University | Parsley (petroselinum crispum) as a remedy for diabetes mellitus |
CA2986449C (en) * | 2015-05-19 | 2021-11-23 | Ralco Nutrition, Inc. | Essential oil compositions and applications utilizing essential oils |
CN106805055A (zh) * | 2015-11-27 | 2017-06-09 | 殷志杰 | 一种具有抗癌作用的养生饮品 |
US20200246449A1 (en) * | 2017-05-03 | 2020-08-06 | Nanobio Corporation | Intravenous immunoglobulin compositions specific for respiratory syncytial virus and methods of making and using the same |
IL257224B (en) * | 2018-01-29 | 2020-01-30 | Kim Sawdayee | Compounds and methods for treating hair and scalp |
EP3843765A4 (en) * | 2018-08-27 | 2022-06-01 | Emerald Health Therapeutics Canada Inc. | THERAPEUTIC COMBINATIONS OF BOSWELLIA EXTRACT AND CANNABINOIDS |
US20200397711A1 (en) * | 2019-06-22 | 2020-12-24 | Gregory Brian LEE | Microparticle compositions for treatment of infection or disease, methods of making the same, and methods of treating subjects with microparticle compositions |
WO2021183995A1 (en) * | 2020-03-13 | 2021-09-16 | Furst-Mcness Company | Compositions and methods for prevention and treatment of viral disorders |
-
2021
- 2021-03-19 WO PCT/IL2021/050310 patent/WO2021186456A1/en active Application Filing
- 2021-03-19 WO PCT/IL2021/050307 patent/WO2021186453A1/en active Application Filing
- 2021-03-19 BR BR112022018645A patent/BR112022018645A2/pt not_active Application Discontinuation
- 2021-03-19 CN CN202180021704.5A patent/CN115666540A/zh active Pending
- 2021-03-19 AU AU2021239186A patent/AU2021239186A1/en active Pending
- 2021-03-19 US US17/912,633 patent/US20230346866A1/en active Pending
- 2021-03-19 CA CA3175442A patent/CA3175442A1/en active Pending
- 2021-03-19 KR KR1020227032801A patent/KR20230005128A/ko unknown
- 2021-03-19 JP JP2022557079A patent/JP2023522298A/ja active Pending
- 2021-03-19 CN CN202180021716.8A patent/CN116096360A/zh active Pending
- 2021-03-19 US US17/912,779 patent/US20230134432A1/en active Pending
- 2021-03-19 JP JP2022557078A patent/JP2023522297A/ja active Pending
- 2021-03-19 JP JP2022557081A patent/JP2023522299A/ja active Pending
- 2021-03-19 MX MX2022011572A patent/MX2022011572A/es unknown
- 2021-03-19 MX MX2022011535A patent/MX2022011535A/es unknown
- 2021-03-19 IL IL296407A patent/IL296407A/en unknown
- 2021-03-19 CA CA3175444A patent/CA3175444A1/en active Pending
- 2021-03-19 WO PCT/IL2021/050309 patent/WO2021186455A1/en active Application Filing
- 2021-03-19 BR BR112022018639A patent/BR112022018639A2/pt not_active Application Discontinuation
- 2021-03-19 EP EP21771187.8A patent/EP4121077A4/en active Pending
- 2021-03-19 AU AU2021236988A patent/AU2021236988A1/en active Pending
- 2021-03-19 EP EP21771261.1A patent/EP4121022A4/en active Pending
- 2021-03-19 BR BR112022018649A patent/BR112022018649A2/pt not_active Application Discontinuation
- 2021-03-19 US US17/912,804 patent/US20240226218A1/en active Pending
- 2021-03-19 MX MX2022011517A patent/MX2022011517A/es unknown
- 2021-03-19 IL IL296398A patent/IL296398A/en unknown
- 2021-03-19 KR KR1020227032802A patent/KR20230005129A/ko unknown
- 2021-03-19 WO PCT/IL2021/050308 patent/WO2021186454A1/en active Application Filing
- 2021-03-19 CA CA3175446A patent/CA3175446A1/en active Pending
- 2021-03-19 MX MX2022011573A patent/MX2022011573A/es unknown
- 2021-03-19 KR KR1020227032803A patent/KR20230005130A/ko unknown
- 2021-03-19 AU AU2021239187A patent/AU2021239187A1/en active Pending
- 2021-03-19 IL IL296399A patent/IL296399A/en unknown
- 2021-03-19 BR BR112022018637A patent/BR112022018637A2/pt not_active Application Discontinuation
- 2021-03-19 EP EP21770842.9A patent/EP4121021A4/en active Pending
- 2021-03-19 EP EP21770533.4A patent/EP4121019A4/en active Pending
- 2021-03-19 CN CN202180021713.4A patent/CN116075314A/zh active Pending
- 2021-03-19 CN CN202180021703.0A patent/CN116056690A/zh active Pending
- 2021-03-19 US US17/912,625 patent/US20230181665A1/en active Pending
- 2021-03-19 JP JP2022557080A patent/JP2023526724A/ja active Pending
- 2021-03-19 IL IL296402A patent/IL296402A/en unknown
- 2021-03-19 AU AU2021237876A patent/AU2021237876A1/en active Pending
- 2021-03-19 KR KR1020227032804A patent/KR20230005131A/ko unknown
- 2021-03-19 CA CA3175440A patent/CA3175440A1/en active Pending
-
2022
- 2022-09-09 ZA ZA2022/10080A patent/ZA202210080B/en unknown
- 2022-09-09 ZA ZA2022/10078A patent/ZA202210078B/en unknown
- 2022-09-09 ZA ZA2022/10076A patent/ZA202210076B/en unknown
- 2022-09-09 ZA ZA2022/10079A patent/ZA202210079B/en unknown
- 2022-09-15 CO CONC2022/0013172A patent/CO2022013172A2/es unknown
- 2022-09-15 CO CONC2022/0013167A patent/CO2022013167A2/es unknown
- 2022-09-15 CO CONC2022/0013171A patent/CO2022013171A2/es unknown
- 2022-09-15 CO CONC2022/0013166A patent/CO2022013166A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2023522298A (ja) | 非悪性呼吸器疾患を処置及び予防するための組成物及び方法 | |
Gupta et al. | Pharmacological potential of Matricaria recutita-A review | |
Harlev et al. | Anticancer attributes of desert plants: a review | |
Mittal et al. | Phytochemistry and pharmacological activities of Psidium guajava | |
Kadry et al. | Antioxidant activity of aerial parts of Tribulus alatus in rats | |
Giordano et al. | Silybum marianum: not Just Silymarin and Flavonolignans. | |
Lee | Korean Ginseng: Composition, Processing, and Health Benefits | |
Peters et al. | Phytochemical and Essential Oil Constituents of Piper Umbellatum Linn Leaves | |
CA3233073A1 (en) | Compositions and methods for treating or preventing inflammatory diseases including diabetes and thyroid diseases | |
Nenni et al. | Medicinal Plants, Secondary Metabolites, and Their Antiallergic Activities | |
Manisha et al. | A review on hepatoprotective activity of medicinal plants | |
Marchart | Qualitative and quantitative analysis of Chinese medical herbs for the prevention and therapy of acute myocardial infarction and diabetes | |
Sahu et al. | PHYTOCHEMICAL SCREENING AND QUANTITATIVE ANALYSIS OF TEPHROSIA PURPUREA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221118 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231031 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240131 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240401 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240604 |